Curriculum Vitae

PROF. DR. CHAN WAH KHEONG

Professor
  • Department of Medicine
    Faculty of Medicine
  • wkchan
  • 0379492965

AREAS OF EXPERTISE


  • GASTROENTEROLOGY
    Diagnostic and Therapeutic Endoscopy, Viral Hepatitis B and C, Hepatocellular Carcinoma, Non-Alcoholic Fatty Liver Disease

ACADEMIC QUALIFICATION


  • PhD, (PERUBATAN)
    Universiti Malaya (UM)
  • MRCP (UK), (LAIN LAIN)
    Royal College of Physicians of Edinburgh, United Kingdom
  • MBBS, (PERUBATAN DAN PEMBEDAHAN)
    Universiti Malaya (UM)

ADMINISTRATIVE DUTIES


  • APPOINTMENT AS THE HEAD OF DIVISION- DIVISION OF GASTROENTEROLOGY & HEPATOLOGY
    01 Nov 2023 - 31 Oct 2025 (Department)
  • Committee Members
    26 May 2023 - 02 Jun 2023 (University Malaya)
  • Research Training Unit Committee Member
    01 Jan 2021 - 31 Dec 2022 (Faculty)
  • Examiner for OSCE 1 Paper for "Required Summative Assessment"
    03 Feb 2021 - 03 Feb 2021 (University Malaya)
  • Trainer for Gastroenterology Training Programme in Malaysia
    23 Nov 2017 - 23 Nov 2020 (National)
  • Thesis Examiner for Master's Degree of Internal Medicine Examination
    17 Nov 2020 - 17 Nov 2020 (University Malaya)
  • Thesis Examiner for Master's Degree of Internal Medicine Examination
    17 Nov 2020 - 17 Nov 2020 (University Malaya)
  • Thesis Examiner for Master's Degree of Internal Medicine Examination
    17 Nov 2020 - 17 Nov 2020 (University Malaya)
  • Examiner OSCE Paper
    02 Sep 2020 - 02 Sep 2020 (University Malaya)
  • Assessor for Candidature Defence (Chairperson)
    14 Jul 2020 - 14 Jul 2020 (University Malaya)
  • Assessor for Thesis Seminar
    25 Jun 2020 - 25 Jun 2020 (University Malaya)
  • Panel for Thesis Proposal Presentation
    23 Jun 2020 - 23 Jun 2020 (University Malaya)
  • A member of the taskforce to update the 2015 CPG for management of T2DM
    18 Jan 2020 - 11 Mar 2020 (National)
  • Examiner for Clinical Examination
    10 Mar 2020 - 10 Mar 2020 (University Malaya)
  • Assessor for Candidature Defence (Chairperson)
    25 Feb 2020 - 25 Feb 2020 (University Malaya)
  • Supervisor
    25 Feb 2020 - 25 Feb 2020 (University Malaya)
  • Assessor for Thesis Seminar (Chairperson)
    05 Feb 2020 - 05 Feb 2020 (University Malaya)
  • Thesis Examiner for Master's Degree Examination of Internal Medicine
    18 Nov 2019 - 18 Nov 2019 (University Malaya)
  • Thesis Examiner for Master's Degree Examination of Internal Medicine
    18 Nov 2019 - 18 Nov 2019 (University Malaya)
  • Thesis Examiner for Master's Degree Examination of Internal Medicine
    18 Nov 2019 - 18 Nov 2019 (University Malaya)
  • Thesis Examiner for Master's Degree Examination of Internal Medicine
    18 Nov 2019 - 18 Nov 2019 (University Malaya)
  • Thesis Examiner for Master's Degree Examination of Internal Medicine
    18 Nov 2019 - 18 Nov 2019 (University Malaya)
  • Thesis Examiner for Master's Degree Examination of Internal Medicine
    18 Nov 2019 - 18 Nov 2019 (University Malaya)
  • Assessor for Master in Medical Sciences Proposal Defence
    16 Oct 2019 - 16 Oct 2019 (University Malaya)
  • Assessor for Proposal Defence (Chairperson)
    12 Sep 2019 - 12 Sep 2019 (University Malaya)
  • Assessor for Proposal Defence
    12 Sep 2019 - 12 Sep 2019 (University Malaya)
  • Assessor for Proposal Defence (Chairperson)
    12 Sep 2019 - 12 Sep 2019 (University Malaya)
  • Assesor for Fundamental Research Grant Scheme (FRGS)
    08 Jul 2019 - 08 Jul 2019 (National)
  • OSCE Paper Examiner for Level 2 Professional Examinations, Session 2017/2018
    08 Aug 2018 - 08 Aug 2018 (University Malaya)
  • Examiner for UM Clinical Examination 2017 - Masters in Internal Medicine Examination
    08 May 2017 - 12 May 2017 (University Malaya)
  • Thesis Examiner for a master's degree of internal medicine examination
    21 Nov 2016 - 21 Nov 2016 (University Malaya)
  • Thesis Examiner for a master's degree of internal medicine examination
    21 Nov 2016 - 21 Nov 2016 (University Malaya)
  • Thesis Examiner for a master's degree of internal medicine examination
    21 Nov 2016 - 21 Nov 2016 (University Malaya)
  • Thesis Examiner for a master's degree of internal medicine examination
    21 Nov 2016 - 21 Nov 2016 (University Malaya)
  • Thesis Examiner for a master's degree of internal medicine examination
    21 Nov 2016 - 21 Nov 2016 (University Malaya)
  • Thesis Examiner for a master's degree of internal medicine examination
    21 Nov 2016 - 21 Nov 2016 (University Malaya)
  • Coordinator
    20 Jun 2016 - 29 Jun 2016 (Department of Medicine, Faculty of Medicine)
  • Examiner for UITM Clinical Examination Part II Session May 2016 (Masters in Internal Medicine Programme)
    17 May 2016 - 17 May 2016 (National)
  • Programme Coordinator
    08 Apr 2016 - 10 Apr 2016 (International)
  • 'Candidature Defence' Evaluation Seminar for Master candidate Lee Hooi leng
    28 Mar 2016 - 29 Mar 2016 (Department of Medicine, Faculty of Medicine)
  • High Degree committee members of medical department
    14 Mar 2016 - 14 Mar 2016 (Department of Medicine, Faculty of Medicine)
  • Quality Manager
    01 Dec 2010 - 31 Dec 2013 (Department of Medicine, Faculty of Medicine)
  • Project Coordinator for the 4th Edition of Accreditation Project under the Standard Malaysian Society for Quality in Health (MSQH)
    07 Nov 2013 - 31 Dec 2013 (Department of Medicine, Faculty of Medicine)
  • Assistant Coordinator for 3rd MBBS (Additional) Clinical Examination
    24 Oct 2011 - 31 Oct 2011 (Department of Medicine, Faculty of Medicine)
  • Assistant Coordinator for 3rd MBBS Clinical Examination
    08 Aug 2011 - 26 Aug 2011 (Department of Medicine, Faculty of Medicine)

MEMBERSHIPS


  • HEPATOLOGY COMMITTEE MEMBER OF THE WORLD GASTROENTEROLOGY ORGANISATION, MEMBER
    2024 to 2024 (International)
  • MEMBER OF THE NATIONAL GASTROENTEROLOGY & HEPATOLOGY TRAINING BOARD 2024-2025, MEMBER
    2024 to present (National)
  • INTERNATIONAL EDITORIAL BOARD MEMBER, EDITORIAL BOARD
    2022 to present (International)
  • INTERNATIONAL EDITORIAL BOARD MEMBER FOR ALIMENTARY PHARMACOLOGY AND THERAPEUTICS, BOARD MEMBER
    2023 to 2023 (International)
  • INTERNATIONAL EDITORIAL BOARD MEMBER FOR CLINICAL AND MOLECULAR HEPATOLOGY, BOARD MEMBER
    2023 to 2023 (International)
  • ASSOCIATE EDITOR FOR JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, BOARD MEMBER
    2023 to 2023 (International)
  • INTERNATIONAL EDITORIAL BOARD MEMBER FOR CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, BOARD MEMBER
    2023 to 2023 (International)
  • ASSOCIATE EDITOR, ASSOCIATE EDITOR
    2021 to 2023 (International)
  • MEMBER, MEMBER
    2019 to 2023 (International)
  • ASSOCIATE EDITOR, ASSOCIATE EDITOR
    2022 to 2022 (International)
  • MEMBER, MEMBER
    2022 to 2022 (International)
  • INTERNATIONAL EDITORIAL BOARD MEMBER, EDITORIAL BOARD
    2020 to 2022 (International)
  • INTERNATIONAL EDITORIAL BOARD MEMBER, EDITORIAL BOARD
    2020 to 2022 (International)
  • ORGANIZING COMMITTEE MEMBER FOR VIRTUAL ASIAN PACIFIC DIGESTIVE WEEK 2021, COMMITTEE MEMBER
    2021 to 2021 (International)
  • SCIENTIFIC CO-CHAIR FOR HEPATOLOGY FOR VIRTUAL ASIAN PACIFIC DIGESTIVE WEEK 2021, COMMITTEE MEMBER
    2021 to 2021 (International)
  • JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, OTHERS
    2018 to 2020 (International)
  • ASIA PACIFIC DIGESTIVE WEEK 2020, OTHERS
    2018 to 2020 (International)
  • ASSOCIATE EDITOR, ASSOCIATE EDITOR
    2018 to 2020 (International)
  • THE ASIA PACIFIC WORKING PARTY ON NON-ALCOHOLIC FATTY LIVER DISEASE, MEMBER
    2016 to 2020 (International)
  • GUT AND OBESITY ASIA, MEMBER
    2014 to 2020 (International)
  • PREVENTION, SURVEILLANCE AND MANAGEMENT OF NON-COMMUNICABLE DISEASES IN PRIMARY AND SECONDARY HEALTH-CARE SETTINGS FOR THE LOW AND MIDDLE INCOME COUNTRIES, OTHERS
    2018 to 2019 (International)
  • JOURNAL OF CLINICAL IMAGING SCIENCE, REVIEWER
    2017 to 2017 (International)
  • JOURNAL OF CLINICAL IMAGING SCIENCE, REVIEWER
    2016 to 2016 (International)

AWARD AND STEWARDSHIP


  • Best Paper Award for Second place in the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2017
    Malaysian Society of Gastroenterology and Hepatology, 2017 (National)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2017 (University)
  • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2016
    Malaysian Society of Gastroenterology and Hepatology, 2016 (National)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2015 (University)
  • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015
    Malaysian Society of Gastroenterology and Hepatology, 2015 (National)
  • Asian Young Endoscopist Award 2015
    Koran Society of Gastrointestinal Endoscopy, 2015 (International)
  • APDWF Posters of Distinction Award
    Asian Pacific Digestive Week Federation, 2015 (International)
  • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015
    Malaysian Society of Gastroenterology and Hepatology, 2015 (National)
  • Poster of Distinction: Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease,at the 23rd Conference of the Asian Pacific Association in the Study of the Liver 2014
    Asian Pacific Association in the Study of the Liver 2014, 2014 (International)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2013 (University)
  • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013
    Malaysian Society of Gastroenterology and Hepatology, 2013 (National)
  • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012
    Malaysian Society of Gastroenterology and Hepatology, 2012 (National)
  • Scholarship as Visiting Scholar to Kyushu University Hospital
    Kyushu University Hospital, 2011 (International)

PUBLICATIONS


Article in Journal
WoS
  1. Chan, Wah-Kheong; George, Jacob (2024). Metabolic fatty liver syndromes: where do we stand in 2024?, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 39(4), 613-614. doi:10.1111/jgh.16507
  2. Chan, Wah-Kheong; Petta, Salvatore; Noureddin, Mazen; Goh, George Boon Bee; Wong, Vincent Wai-Sun (2024). Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity, ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 59, S23-S40. doi:10.1111/apt.17866
  3. Chan, Wah-Kheong; Wong, Vincent Wai-Sun; Adams, Leon A.; Nguyen, Mindie H. (2024). MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD, HEPATOLOGY INTERNATIONAL. 18(SUPPL 2), 909-921. doi:10.1007/s12072-024-10661-x
  4. Chee, Nicholas Ming-Zher; Sinnanaidu, Ram Prasad; Chan, Wah-Kheong (2024). Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. . doi:10.1111/jgh.16723
  5. Leow, Yong Wen; Chan, Wah Loong; Lai, Lee Lee; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv; Quiambao, Ronald; Munteanu, Mona; Chan, Wah Kheong (2024). LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 39(10), 2182-2189. doi:10.1111/jgh.16675
  6. Lin, Huapeng; Lee, Hye Won; Yip, Terry Cheuk-Fung; Tsochatzis, Emmanuel; Petta, Salvatore; Bugianesi, Elisabetta; Yoneda, Masato; Zheng, Ming-Hua; Hagstrom, Hannes; Boursier, Jerome; Calleja, Jose Luis; Goh, George Boon-Bee; Chan, Wah-Kheong; Gallego-Duran, Rocio; Sanyal, Arun J.; de Ledinghen, Victor; Newsome, Philip N.; Fan, Jian-Gao; Castera, Laurent; Lai, Michelle; Harrison, Stephen A.; Fournier-Poizat, Celine; Wong, Grace Lai-Hung; Pennisi, Grazia; Armandi, Angelo; Nakajima, Atsushi; Liu, Wen-Yue; Shang, Ying; de Saint-Loup, Marc; Llop, Elba; Teh, Kevin Kim-Jun; Lara-Romero, Carmen; Asgharpour, Amon; Mahgoub, Sara; Chan, Mandy Sau-Wai; Canivet, Clemence M.; Romero-Gomez, Manuel; Kim, Seung Up; Wong, Vincent Wai-Sun (2024). Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 331(15), 1287-1297. doi:10.1001/jama.2024.1447
  7. Mozes, Ferenc E.; Lee, Jenny A.; Vali, Yasaman; Selvaraj, Emmanuel A.; Jayaswal, Arjun N. A.; Boursier, Jerome; de Ledinghen, Victor; Lupsor-Platon, Monica; Yilmaz, Yusuf; Chan, Wah-Kheong; Mahadeva, Sanjiv; Karlas, Thomas; Wiegand, Johannes; Tsochatzis, Emmanouil; Liguori, Antonio; Wong, Vincent Wai-Sun; Lee, Dae Ho; Holleboom, Adriaan G.; van Dijk, Anne-Marieke; Mak, Anne Linde; Hagstroem, Hannes; Akbari, Camilla; Hirooka, Masashi; Lee, Dong Hyeon; Kim, Won; Okanoue, Takeshi; Shima, Toshihide; Nakajima, Atsushi; Yoneda, Masato; Thuluvath, Paul J.; Li, Feng; Berzigotti, Annalisa; Mendoza, Yuly P.; Noureddin, Mazen; Truong, Emily; Fournier-Poizat, Celine; Geier, Andreas; Tuthill, Theresa; Yunis, Carla; Anstee, Quentin M.; Harrison, Stephen A.; Bossuyt, Patrick M.; Pavlides, Michael (2024). Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis, LIVER INTERNATIONAL. 44(8), 1872-1885. doi:10.1111/liv.15914
  8. Sun, Chao; Goh, George Boon-Bee; Chow, Wan-Cheng; Chan, Wah-Kheong; Wong, Grace Lai-Hung; Seto, Wai-Kay; Huang, Yi-Hsiang; Lin, Han-Chieh; Lee, I-Cheng; Lee, Hye Won; Kim, Seung Up; Wong, Vincent Wai-Sun; Fan, Jian-Gao (2024). Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease, HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL. 23(3), 241-248. doi:10.1016/j.hbpd.2023.08.004
  9. Verma, Nipun; Duseja, Ajay; Mehta, Manu; De, Arka; Lin, Huapeng; Wong, Vincent Wai-Sun; Wong, Grace Lai-Hung; Rajaram, Ruveena Bhavani; Chan, Wah-Kheong; Mahadeva, Sanjiv; Zheng, Ming-Hua; Liu, Wen-Yue; Treeprasertsuk, Sombat; Prasoppokakorn, Thaninee; Kakizaki, Satoru; Seki, Yosuke; Kasama, Kazunori; Charatcharoenwitthaya, Phunchai; Sathirawich, Phalath; Kulkarni, Anand; Purnomo, Hery Djagat; Kamani, Lubna; Lee, Yeong Yeh; Wong, Mung Seong; Tan, Eunice X. X.; Young, Dan Yock (2024). Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study, ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 59(6), 774-788. doi:10.1111/apt.17891
  10. Wan, Kim Sui; Chan, Wah-Kheong; Yusoff, Muhammad Fadhli Mohd; Mustapha, Feisul; Rifin, Halizah Mat; Ratnam, Kishwen Kanna Yoga; Ahmad, Noor Ani (2024). Correspondence: "A multisociety Delphi consensus statement on new fatty liver disease nomenclature ", ANNALS OF HEPATOLOGY. 29(4). doi:10.1016/j.aohep.2024.101485
  11. Younossi, Zobair M.; AlQahtani, Saleh A.; Funuyet-Salas, Jesus; Romero-Gomez, Manuel; Yilmaz, Yusuf; Keklikkiran, Caglayan; Alswat, Khalid; Yu, Ming-Lung; Liu, Chun-Jen; Fan, Jian-Gao; Zheng, Ming-Hua; Burra, Patrizia; Francque, Sven M.; Castera, Laurent; Schattenberg, Joern M.; Newsome, Philip N.; Allen, Alina M.; El-Kassas, Mohamed; Treeprasertsuk, Sombat; Hameed, Saeed; Wong, Vincent Wai-Sun; Zelber-Sagi, Shira; Takahashi, Hirokazu; Kawaguchi, Takumi; Fernandez, Marlen I. Castellanos; Duseja, Ajay; Arrese, Marco; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart C.; Fuchs, Michael; Eskridge, Wayne; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Gerber, Lynn; Lam, Brian; Fornaresio, Lisa; Nader, Fatema; Spearman, C. Wendy; Roberts, Stuart K.; Chan, Wah-Kheong; Silva, Marcelo; Racila, Andrei; Golabi, Pegah; Ananchuensook, Prooksa; Henry, Linda; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey, V (2024). The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease, JHEP REPORTS. 6(7). doi:10.1016/j.jhepr.2024.101066
  12. Younossi, Zobair M.; Alqahtani, Saleh A.; Alswat, Khalid; Yilmaz, Yusuf; Keklikkiran, Caglayan; Funuyet-Salas, Jesus; Romero-Gomez, Manuel; Fan, Jian-Gao; Zheng, Ming-Hua; El-Kassas, Mohamed; Castera, Laurent; Liu, Chun-Jen; Wong, Vincent Wai-Sun; Zelber-Sagi, Shira; Allen, Alina M.; Lam, Brian; Treeprasertsuk, Sombat; Hameed, Saeed; Takahashi, Hirokazu; Kawaguchi, Takumi; Schattenberg, Joern M.; Duseja, Ajay; Newsome, Phil N.; Francque, Sven; Spearman, C. Wendy; Fernandez, Marlen I. Castellanos; Burra, Patrizia; Roberts, Stuart K.; Chan, Wah-Kheong; Arrese, Marco; Silva, Marcelo; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart; Fuchs, Michael; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Eskridge, Wayne; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Yu, Ming-Lung; Gerber, Lynn; Fornaresio, Lisa; Nader, Fatema; Henry, Linda; Racila, Andrei; Golabi, Pegah; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey, V (2024). Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease, JOURNAL OF HEPATOLOGY. 80(3). doi:10.1016/j.jhep.2023.11.004
  13. Zeng, Xu-Fen; Varady, Krista A.; Wang, Xiang-Dong; Targher, Giovanni; Byrne, Christopher D.; Tayyem, Reema; Latella, Giovanni; Bergheim, Ina; Valenzuela, Rodrigo; George, Jacob; Newberry, Carolyn; Zheng, Ju-Sheng; George, Elena S.; Spearman, C. Wendy; Kontogianni, Meropi D.; Ristic-Medic, Danijela; Peres, Wilza Arantes Ferreira; Depboylu, Gamze Yurtdas; Yang, Wanshui; Chen, Xu; Rosqvist, Fredrik; Mantzoros, Christos S.; Valenti, Luca; Yki-Jaervinen, Hannele; Mosca, Antonella; Sookoian, Silvia; Misra, Anoop; Yilmaz, Yusuf; Kim, Won; Fouad, Yasser; Sebastiani, Giada; Wong, Vincent Wai-Sun; Aberg, Fredrik; Wong, Yu Jun; Zhang, Pianhong; Bermudez-Silva, Francisco-Javier; Ni, Yan; Lupsor-Platon, Monica; Chan, Wah Kheong; Mendez-Sanchez, Nahum; Knegt, Robert J. de; Alam, Shahinul; Treeprasertsuk, Sombat; Wang, Li; Du, Mulong; Zhang, Tiejun; Yu, Ming-Lung; Zhang, Huijie; Qi, Xingshun; Liu, Xin; Pinyopornpanish, Kanokwan; Fan, Yu-Chen; Niu, Kaijun; Jimenez-Chillaron, Josep C.; Zheng, Ming-Hua (2024). The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus, METABOLISM-CLINICAL AND EXPERIMENTAL. 161. doi:10.1016/j.metabol.2024.156028
  14. Zhang, Huai; Targher, Giovanni; Byrne, Christopher D.; Kim, Seung Up; Wong, Vincent Wai-Sun; Valenti, Luca; Glickman, Myer; Ponce, Jaime; Mantzoros, Christos S.; Crespo, Javier; Gronbaek, Henning; Yang, Wah; Eslam, Mohammed; Wong, Robert J.; Machado, Mariana Verdelho; Yu, Ming-Lung; Ghanem, Omar M.; Okanoue, Takeshi; Liu, Jun-Feng; Lee, Yong-ho; Xu, Xiao-Yuan; Pan, Qiuwei; Sui, Meili; Lonardo, Amedeo; Yilmaz, Yusuf; Zhu, Li-Yong; Moreno, Christophe; Miele, Luca; Lupsor-Platon, Monica; Zhao, Lei; LaMasters, Teresa LeAnn; Gish, Robert G.; Zhang, Huijie; Nedelcu, Marius; Chan, Wah Kheong; Xia, Ming-Feng; Bril, Fernando; Shi, Jun-Ping; Datz, Christian; Romeo, Stefano; Sun, Jian; Liu, Dan; Sookoian, Silvia; Mao, Yi-Min; Mendez-Sanchez, Nahum; Wang, Xiao-Yan; Pyrsopoulos, Nikolaos T.; Fan, Jian-Gao; Fouad, Yasser; Sun, Dan-Qin; Giannini, Cosimo; Chai, Jin; Xia, Ze-Feng; Jun, Dae Won; Li, Guo-Jing; Treeprasertsuk, Sombat; Li, Ying-Xu; Cheung, Tan To; Zhang, Faming; Goh, George Boon-Bee; Furuhashi, Masato; Seto, Wai-Kay; Huang, Hui; Di Sessa, Anna; Li, Qing-Hong; Cholongitas, Evangelos; Zhang, Le; Silveira, Themis Reverbel; Sebastiani, Giada; Adams, Leon A.; Chen, Wei; Qi, Xiaolong; Rankovic, Ivan; De Ledinghen, Victor; Lv, Wen-Jie; Hamaguchi, Masahide; Kassir, Radwan; Mueller-Wieland, Dirk; Romero-Gomez, Manuel; Xu, Ying; Xu, Yi-Cong; Chen, Shi-Yao; Kermansaravi, Mohammad; Kuchay, Mohammad Shafi; Lefere, Sander; Parmar, Chetan; Lip, Gregory Y. H.; Liu, Chun-Jen; Aberg, Fredrik; Lau, George; George, Jacob; Sarin, Shiv Kumar; Zhou, Jing-Ya; Zheng, Ming-Hua (2024). A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease, HEPATOLOGY INTERNATIONAL. . doi:10.1007/s12072-024-10702-5
  15. Zhang, Huai; Zhou, Xiao-Dong; Shapiro, Michael D.; Lip, Gregory Y. H.; Tilg, Herbert; Valenti, Luca; Somers, Virend K.; Byrne, Christopher D.; Targher, Giovanni; Yang, Wah; Viveiros, Octavio; Opio, Christopher Kenneth; Mantzoros, Christos S.; Ryan, John D.; Kok, Kenneth Yuh Yen; Jumaev, Nozim Adxamovich; Perera, Nilanka; Robertson, Andrew Gerard; Abu-Abeid, Adam; Misra, Anoop; Wong, Yu Jun; Ruiz-Ucar, Elena; Ospanov, Oral; Kizilkaya, Mehmet Celal; Luo, Fei; Mendez-Sanchez, Nahum; Zuluaga, Mauricio; Lonardo, Amedeo; Al Momani, Hazem; Toro-Huamanchumo, Carlos Jesus; Adams, Leon; Al-Busafi, Said A.; Sharara, Ala I.; Chan, Wah-Kheong; Abbas, Syed Imran; Sookoian, Silvia; Treeprasertsuk, Sombat; Ocama, Ponsiano; Alswat, Khalid; Kong, Alice Pik-Shan; Ataya, Karim; Lim-Loo, Michelle Ching; Oviedo, Rodolfo J.; Szepietowski, Olivia; Fouad, Yasser; Zhang, Huijie; Abdelbaki, Tamer N.; Katsouras, Christos S.; Prasad, Arun; Thaher, Omar; Ali, Arshad; Molina, Gabriel Alejandro; Sung, Ki-Chul; Chen, Qin-Fen; Lesmana, Cosmas Rinaldi Adithya; Zheng, Ming-Hua (2024). Global burden of metabolic diseases, 1990-2021021, METABOLISM-CLINICAL AND EXPERIMENTAL. 160. doi:10.1016/j.metabol.2024.155999
  16. Zhou, Xiao-Dong; Kim, Seung Up; Yip, Terry Cheuk-Fung; Petta, Salvatore; Nakajima, Atsushi; Tsochatzis, Emmanuel; Boursier, Jerome; Bugianesi, Elisabetta; Hagstrom, Hannes; Chan, Wah Kheong; Romero-Gomez, Manuel; Calleja, Jose Luis; de Ledinghen, Victor; Castera, Laurent; Sanyal, Arun J.; Goh, George Boon-Bee; Newsome, Philip N.; Fan, Jiangao; Lai, Michelle; Fournier-Poizat, Celine; Lee, Hye Won; Wong, Grace Lai-Hung; Armandi, Angelo; Shang, Ying; Pennisi, Grazia; Llop, Elba; Yoneda, Masato; de Saint-Loup, Marc; Canivet, Clemence M.; Lara-Romero, Carmen; Gallego-Duran, Rocio; Asgharpour, Amon; Teh, Kevin Kim-Jun; Mahgoub, Sara; Chan, Mandy Sau-Wai; Lin, Huapeng; Liu, Wen-Yue; Targher, Giovanni; Byrne, Christopher D.; Wong, Vincent Wai-Sun; Zheng, Ming-Hua (2024). Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease, GUT. . doi:10.1136/gutjnl-2024-333074
  17. Alqahtani, Saleh A.; Chan, Wah-Kheong; Yu, Ming-Lung (2023). Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma, CLINICS IN LIVER DISEASE. 27(2), 211-223. doi:10.1016/j.cld.2023.01.019
  18. Chan, Wah Loong; Chong, Shi-En; Chang, Felicia; Chuah, Kee Huat; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv; Chan, Wah-Kheong (2023). Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy, HEPATOLOGY INTERNATIONAL. . doi:10.1007/s12072-023-10550-9
  19. Chan, Wah Loong; Kumar, C. Vikneshwaran Chandra; Chan, Wah Kheong (2023). Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis, HEPATOBILIARY SURGERY AND NUTRITION. 12(5), 763-767. doi:10.21037/hbsn-23-346
  20. Chan, Wah-Kheong (2023). Comparison between obese and non-obese nonalcoholic fatty liver disease, CLINICAL AND MOLECULAR HEPATOLOGY. 29, S58-S67. doi:10.3350/cmh.2022.0350
  21. Cheung, Johnny T. K.; Chan, Wah Kheong; Zheng, Ming-Hua; Wong, Vincent Wai-Sun (2023). Assessing advanced fibrosis in metabolic-associated steatotic liver disease-the MAFLD fibrosis score. Authors' reply, ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 58(11-12), 1236-1237. doi:10.1111/apt.17774
  22. Cheung, Johnny T. K.; Zhang, Xinrong; Wong, Grace Lai-Hung; Yip, Terry Cheuk-Fung; Lin, Huapeng; Li, Guanlin; Leung, Howard Ho-Wai; Lai, Jimmy Che-To; Mahadeva, Sanjiv; Mustapha, Nik Raihan Nik; Wang, Xiao-Dong; Liu, Wen-Yue; Wong, Vincent Wai-Sun; Chan, Wah-Kheong; Zheng, Ming-Hua (2023). MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease, ALIMENTARY PHARMACOLOGY & THERAPEUTICS. . doi:10.1111/apt.17722
  23. Chong, Shi-En; Chang, Felicia; Chuaha, Kee-Huat; Sthaneshwar, Pavai; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv; Chan, Wah-Kheong (2023). Validation of the Hepamet fibrosis score in a multi-ethnic Asian population, ANNALS OF HEPATOLOGY. 28(2). doi:10.1016/j.aohep.2022.100888
  24. Chuah, Kee-Huat; Chan, Wah-Kheong (2023). Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future, CLINICAL AND MOLECULAR HEPATOLOGY. 29, S171-S183. doi:10.3350/cmh.2022.0426
  25. El-Kassas, Mohamed; Yilmaz, Yusuf; Liu, Chun-Jen; Fernandez, Marlen Ivon Castellanos; Chan, Wah Kheong; Papatheodoridis, George V.; Nasr, Mohammed Ahmed Medhat; Nader, Fatema; Racila, Andrei; Stepanova, Maria; Younossi, Zobair M. (2023). A GLOBAL SURVEY OF PHYSICIAN KNOWLEDGE ABOUT MANAGEMENT OF CHRONIC HEPATITIS C, HEPATOLOGY. 78, S671-S671
  26. Leow, Yong Wen; Lai, Lee Lee; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv; Quiambao, Ronald; Munteanu, Mona; Chan, Wah Kheong (2023). VALIDATION OF LIVERFAST- GP plus ( GP plus ) AS A NONINVASIVE TEST FOR RISK STRATIFICATION FOR PATIENTS WITH NON- ALCOHOLIC FATTY LIVER DISEASE ( NAFLD): SINGLECENTRE STUDY USING LIVER BIOPSY AS REFERENCE STANDARD., HEPATOLOGY. 78, S903-S904
  27. Leow, Yong-Wen; Chan, Wah-Kheong (2023). Response to letter to editor: Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B, JOURNAL OF VIRAL HEPATITIS. 30(8), 712-712. doi:10.1111/jvh.13858
  28. Leow, Yong-Wen; Chan, Wah-Kheong; Goh, George Boon-Bee; Wong, Vincent Wai-Sun; Fan, Jian Gao; Kim, Young Seok; Kim, Seung Up; Nakajima, Atsushi; Seto, Wai-Kay; Lee, I-Cheng; Huang, Yi-Hsiang; Kim, Yoon Jun; Young, Jang Jae; Chow, Wan Cheng (2023). Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study, JOURNAL OF VIRAL HEPATITIS. . doi:10.1111/jvh.13796
  29. Lin, Huapeng; Lee, Hye Won; Yip, Terry Cheuk-Fung; Tsochatzis, Emmanuel A.; Petta, Salvatore; Bugianesi, Elisabetta; Yoneda, Masato; Zheng, Ming-Hua; Hagstrom, Hannes; Boursier, Jerome; Luis Calleja, Jose; Goh, George Boon-Bee; Chan, Wah Kheong; Romero-Gomez, Manuel; Sanyal, Arun; De Ledinghen, Victor; Newsome, Philip N.; Fan, Jian-Gao; Castera, Laurent; Lai, Michelle; Harrison, Stephen A.; Fournier-Poizat, Celine D.; Wong, Grace Lai-Hung; Pennisi, Grazia; Armandi, Angelo; Nakajima, Atsushi; Liu, Wen Yue; Shang, Ying; De Saint Loup, Marc; Llop, Elba; Teh, Kevin Kim Jun; Lara Romero, Carmen; Asgharpour, Amon; Mahgoub, Sara; Chan, Mandy; Canivet, Clemence; Gallego-Duran, Racio; Kim, Seung Up; Wong, Vincent Wai-Sun (2023). SERIAL VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY (VCTE)-BASED AGILE SCORES PREDICT LIVER-RELATED EVENTS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) - A MULTICENTER COHORT STUDY OF 16,603 PATIENTS, HEPATOLOGY. 78, S876-S880
  30. Mozes, Ferenc Emil; Kaur, Senamjit; Vali, Yasaman; Alzoubi, Osama; Wong, Vincent Wai-Sun; Li, Guanlin; Wong, Grace Lai-Hung C.; Staufer, Katharina; Trauner, Michael; Paternostro, Rafael; Stauber, Rudolf E.; Bugianesi, Elisabetta; Gaia, Silvia; Armandi, Angelo; Lupsor-Platon, Monica; Sebastiani, Giada; Mahadeva, Sanjiv; Rajaram, Ruveena; Zheng, Ming-Hua; George, Jacob; Eslam, Mohammed M.; Pennisi, Grazia; Aithal, Guruprasad P.; Palaniyappan, Naaventhan; Lee, Daeho; Nasr, Patrik; Cassinotto, Christophe; De Ledinghen, Victor; Berzigotti, Annalisa; Mendoza, Yuly Paulin; Noureddin, Mazen; Truong, Emily; Boursier, Jerome; De Saint Loup, Marc; Hirooka, Masashi; Shima, Toshihide; Dr Shalimar; Hagstrom, Hannes; Ekstedt, Mattias; Akbari, Camilla; Chan, Wah Kheong; Tsochatzis, Emmanuel A.; Liguori, Antonio; Petta, Salvatore; Vigano, Mauro; Ridolfo, Sofia; Yoneda, Masato; Nakajima, Atsushi; Holleboom, Adriaan G.; Van Dijk, Anne-Marieke; Mak, Anne Linde; Cobbold, Jeremy F. L.; Karlas, Thomas; Wiegand, Johannes; Fournier, Celine; Martic, Miljen; Tuthill, Theresa; Yunis, Carla; Anstee, Quentin M.; Harrison, Stephen; Bossuyt, Patrick; Pavlides, Michael (2023). LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE, HEPATOLOGY. 78, S995-S998
  31. Mozes, Ferenc Emil; Kaur, Senamjit; Vali, Yasaman; Alzoubi, Osama; Wong, Vincent Wai-Sun; Li, Guanlin; Wong, Grace Lai-Hung C.; Staufer, Katharina; Trauner, Michael; Paternostro, Rafael; Stauber, Rudolf E.; Bugianesi, Elisabetta; Gaia, Silvia; Armandi, Angelo; Lupsor-Platon, Monica; Sebastiani, Giada; Mahadeva, Sanjiv; Rajaram, Ruveena; Zheng, Ming-Hua; George, Jacob; Eslam, Mohammed M.; Pennisi, Grazia; Aithal, Guruprasad P.; Palaniyappan, Naaventhan; Lee, Daeho; Nasr, Patrik; Cassinotto, Christophe; De Ledinghen, Victor; Berzigotti, Annalisa; Mendoza, Yuly Paulin; Noureddin, Mazen; Truong, Emily; Boursier, Jerome; De Saint Loup, Marc; Hirooka, Masashi; Shima, Toshihide; Dr Shalimar; Hagstrom, Hannes; Ekstedt, Mattias; Akbari, Camilla; Chan, Wah Kheong; Tsochatzis, Emmanuel A.; Liguori, Antonio; Petta, Salvatore; Vigano, Mauro; Ridolfo, Sofia; Yoneda, Masato; Nakajima, Atsushi; Holleboom, Adriaan G.; Van Dijk, Anne-Marieke; Mak, Anne Linde; Cobbold, Jeremy F. L.; Karlas, Thomas; Wiegand, Johannes; Fournier, Celine; Martic, Miljen; Tuthill, Theresa; Yunis, Carla; Anstee, Quentin M.; Harrison, Stephen; Bossuyt, Patrick; Pavlides, Michael (2023). NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD, HEPATOLOGY. 78, S1018-S1020
  32. Mozes, Ferenc Emil; Kaur, Senamjit; Vali, Yasaman; Alzoubi, Osama; Wong, Vincent Wai-Sun; Li, Guanlin; Wong, Grace Lai-Hung C.; Staufer, Katharina; Trauner, Michael; Paternostro, Rafael; Stauber, Rudolf E.; Bugianesi, Elisabetta; Gaia, Silvia; Armandi, Angelo; Lupsor-Platon, Monica; Sebastiani, Giada; Mahadeva, Sanjiv; Rajaram, Ruveena; Zheng, Ming-Hua; George, Jacob; Eslam, Mohammed M.; Pennisi, Grazia; Aithal, Guruprasad P.; Palaniyappan, Naaventhan; Lee, Daeho; Nasr, Patrik; Cassinotto, Christophe; De Ledinghen, Victor; Berzigotti, Annalisa; Mendoza, Yuly Paulin; Noureddin, Mazen; Truong, Emily; Boursier, Jerome; De Saint Loup, Marc; Hirooka, Masashi; Shima, Toshihide; Shalimar, Dr; Hagstrom, Hannes; Ekstedt, Mattias; Akbari, Camilla; Chan, Wah Kheong; Tsochatzis, Emmanuel A.; Liguori, Antonio; Petta, Salvatore; Vigano, Mauro; Ridolfo, Sofia; Yoneda, Masato; Nakajima, Atsushi; Holleboom, Adriaan G.; Van Dijk, Anne-Marieke; Mak, Anne Linde; Cobbold, Jeremy F. L.; Karlas, Thomas; Wiegand, Johannes; Fournier, Celine; Martic, Miljen; Tuthill, Theresa; Yunis, Carla; Anstee, Quentin M.; Harrison, Stephen; Bossuyt, Patrick; Pavlides, Michael (2023). COMPOSITE SCORES THAT INCLUDE LIVER STIFFNESS MEASUREMENT CAN PREDICT OUTCOMES IN PATIENTS WITH NAFLD, HEPATOLOGY. 78, S932-S935
  33. Mozes, Ferenc Emil; Kaur, Senamjit; Vali, Yasaman; Alzoubi, Osama; Wong, Vincent Wai-Sun; Li, Guanlin; Wong, Grace Lai-Hung C.; Staufer, Katharina; Trauner, Michael; Paternostro, Rafael; Stauber, Rudolf E.; Bugianesi, Elisabetta; Gaia, Silvia; Armandi, Angelo; Lupsor-Platon, Monica; Sebastiani, Giada; Mahadeva, Sanjiv; Rajaram, Ruveena; Zheng, Ming-Hua; George, Jacob; Eslam, Mohammed M.; Pennisi, Grazia; Aithal, Guruprasad P.; Palaniyappan, Naaventhan; Lee, Daeho; Nasr, Patrik; Cassinotto, Christophe; De Ledinghen, Victor; Berzigotti, Annalisa; Mendoza, Yuly Paulin; Noureddin, Mazen; Truong, Emily; Boursier, Jerome; De Saint Loup, Marc; Hirooka, Masashi; Shima, Toshihide; Shalimar; Hagstrom, Hannes; Ekstedt, Mattias; Akbari, Camilla; Chan, Wah Kheong; Tsochatzis, Emmanuel A.; Liguori, Antonio; Petta, Salvatore; Vigano, Mauro; Ridolfo, Sofia; Yoneda, Masato; Nakajima, Atsushi; Holleboom, Adriaan G.; Van Dijk, Anne-Marieke; Mak, Anne Linde; Cobbold, Jeremy F. L.; Karlas, Thomas; Wiegand, Johannes; Fournier, Celine; Martic, Miljen; Tuthill, Theresa; Yunis, Carla; Anstee, Quentin M.; Harrison, Stephen; Bossuyt, Patrick; Pavlides, Michael (2023). CLASSIFICATION ACCORDING TO SEQUENTIALLY COMBINED NON-INVASIVE TESTS CARRIES PROGNOSTIC VALUE IN PATIENTS WITH NAFLD, HEPATOLOGY. 78, S928-S931
  34. Mozes, Ferenc Emil; Kaur, Senamjit; Vali, Yasaman; Alzoubi, Osama; Wong, Vincent Wai-Sun; Li, Guanlin; Wong, Grace Lai-Hung C.; Staufer, Katharina; Trauner, Michael; Paternostro, Rafael; Stauber, Rudolf E.; Bugianesi, Elisabetta; Gaia, Silvia; Armandi, Angelo; Lupsor-Platon, Monica; Sebastiani, Giada; Mahadeva, Sanjiv; Rajaram, Ruveena; Zheng, Ming-Hua; George, Jacob; Eslam, Mohammed M.; Pennisi, Grazia; Aithal, Guruprasad P.; Palaniyappan, Naaventhan; Lee, Daeho; Nasr, Patrik; Cassinotto, Christophe; De Ledinghen, Victor; Berzigotti, Annalisa; Mendoza, Yuly Paulin; Noureddin, Mazen; Truong, Emily; Boursier, Jerome; De Saint Loup, Marc; Hirooka, Masashi; Shima, Toshihide; Shalimar; Hagstrom, Hannes; Ekstedt, Mattias; Akbari, Camilla; Chan, Wah Kheong; Tsochatzis, Emmanuel A.; Liguori, Antonio; Petta, Salvatore; Vigano, Mauro; Ridolfo, Sofia; Yoneda, Masato; Nakajima, Atsushi; Holleboom, Adriaan G.; Van Dijk, Anne-Marieke; Mak, Anne Linde; Cobbold, Jeremy F. L.; Karlas, Thomas; Wiegand, Johannes; Fournier, Celine; Martic, Miljen; Tuthill, Theresa; Yunis, Carla; Anstee, Quentin M.; Harrison, Stephen; Bossuyt, Patrick; Pavlides, Michael (2023). HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD, HEPATOLOGY. 78, S971-S974
  35. Sanyal, Arun J.; Foucquier, Julie; Younossi, Zobair M.; Harrison, Stephen A.; Newsome, Philip N.; Chan, Wah-Kheong; Yilmaz, Yusuf; De Ledinghen, Victor; Costentin, Charlotte; Zheng, Ming-Hua; Wong, Vincent Wai-Sun; Elkhashab, Magdy; Huss, Ryan S.; Myers, Robert P.; Roux, Marine; Labourdette, Aymeric; Destro, Marie; Fournier-Poizat, Celine; Miette, Veronique; Sandrin, Laurent; Boursier, Jerome (2023). Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores, JOURNAL OF HEPATOLOGY. 78(2). doi:10.1016/j.jhep.2022.10.034
  36. Shahrani, Shahreedhan; Gill, Sandeep Singh; Sooi, Choong Yeong; Skantha, Ruben; Kumar, C. Vikneshwaran Chandra; Limun, Mohd Fairul; Affendi, Nik Arsyad Nik Muhamad; Chuah, Kee Huat; Khoo, Stanley; Rajaram, Ruveena Bhavani; Chan, Wah Kheong; Mahadeva, Sanjiv (2023). Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. . doi:10.1111/jgh.16313
  37. Sripongpun, Pimsiri; Treeprasertsuk, Sombat; Charatcharoenwitthaya, Phunchai; Kaewdech, Apichat; Chamroonkul, Naichaya; Chan, Wah Kheong; Ng, Cheng Han; Muthiah, Mark Dhinesh; Dan, Yock Young; Kim, W. Ray (2023). THE UTILITY OF SEQUENTIAL SAFE SCORE AND FIBROSCAN IN PREDICTING CLINICALLY SIGNIFICANT FIBROSIS IN ASIAN NAFLD PATIENTS., HEPATOLOGY. 78, S889-S890
  38. Sun, Dan-Qin; Targher, Giovanni; Byrne, Christopher D.; Wheeler, David C.; Wong, Vincent Wai-Sun; Fan, Jian-Gao; Tilg, Herbert; Yuan, Wei-Jie; Wanner, Christoph; Gao, Xin; Long, Michelle T.; Kanbay, Mehmet; Nguyen, Mindie H.; Navaneethan, Sankar D.; Yilmaz, Yusuf; Huang, Yuli; Gani, Rino A.; Marzuillo, Pierluigi; Boursier, Jerome; Zhang, Huijie; Jung, Chan-Young; Chai, Jin; Valenti, Luca; Papatheodoridis, George; Musso, Giovanni; Wong, Yu-Jun; El-Kassas, Mohamed; Mendez-Sanchez, Nahum; Sookoian, Silvia; Pavlides, Michael; Duseja, Ajay; Holleboom, Adriaan G.; Shi, Junping; Chan, Wah-Kheong; Fouad, Yasser; Yang, Junwei; Treeprasertsuk, Sombat; Cortez-Pinto, Helena; Hamaguchi, Masahide; Romero-Gomez, Manuel; Al Mahtab, Mamun; Ocama, Ponsiano; Nakajima, Atsushi; Dai, Chunsun; Eslam, Mohammed; Wei, Lai; George, Jacob; Zheng, Ming-Hua (2023). An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease, HEPATOBILIARY SURGERY AND NUTRITION. . doi:10.21037/hbsn-22-421
  39. Wong, Wei-Kei; Chan, Wah-Kheong; Ganapathy, Shubash; Lim, Soo-Kun (2023). Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo-responsiveness among patients with end-stage kidney disease on haemodialysis?, NEPHROLOGY. . doi:10.1111/nep.14186
  40. Yip, Terry Cheuk-Fung; Wong, Grace Lai -Hung; Wong, Vincent Wai-Sun; Goh, George Boon -Bee; Chan, Wah-Kheong (2023). Nonalcoholic Fatty Liver Disease A Unique Entity or Part of the Metabolic Syndrome or Both, MEDICAL CLINICS OF NORTH AMERICA. 107(3), 449-463. doi:10.1016/j.mcna.2022.12.003
  41. Younossi, Zobair M.; Yilmaz, Yusuf; Yu, Ming-Lung; Wong, Vincent Wai-Sun; Fernandez, Marlen Ivon Castellanos, Sr.; Isakov, Vasily A.; Duseja, Ajay K.; Mendez-Sanchez, Nahum; Eguchi, Yuichiro; Bugianesi, Elisabetta; Burra, Patrizia; George, Jacob; Fan, Jian-Gao; Papatheodoridis, George V.; Buti, Maria, Sr.; Chan, Wah Kheong; Alswat, Khalid Aida; Hamid, Saeed S.; Singal, Ashwani K.; Romero-Gomez, Manuel; Gordon, Stuart C.; Roberts, Stuart; El Kassas, Mohamed; Esmat, Gamal; Kugelmas, Marcelo; Ong, Janus; Lam, Brian P.; Younossi, Issah; Racila, Andrei; Henry, Linda; Stepanova, Maria; Alqahtani, Saleh (2023). NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH SIGNIFICANT IMPAIRMENT OF WORK PRODUCTIVITY: DATA FROM THE GLOBAL NASH REGISTRY , HEPATOLOGY. 77(5), E134-E135
  42. Younossi, Zobair M.; Yu, Ming-Lung; Yilmaz, Yusuf; Alswat, Khalid Aida; Buti, Maria; Fernandez, Marlen Ivon Castellanos; Papatheodoridis, Georgios; Hamid, Saeed S.; El-Kassas, Mohamed; Chan, Wah Kheong; Duseja, Ajay K.; Gordon, Stuart C.; Eguchi, Yuichiro; Isakov, Vasily A.; Roberts, Stuart K.; Fan, Jian-Gao; Singal, Ashwani K.; Romero-Gomez, Manuel; Ahmed, Aijaz; Ong, Janus; Lam, Brian P.; Younossi, Issah; Nader, Fatema; Racila, Andrei; Stepanova, Maria; Alqahtani, Saleh (2023). Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry , JOURNAL OF VIRAL HEPATITIS. 30(4), 335-344. doi:10.1111/jvh.13800
  43. Zhang, Huai; Rios, Rafael S.; Boursier, Jerome; Anty, Rodolphe; Chan, Wah-Kheong; George, Jacob; Yilmaz, Yusuf; Wong, Vincent Wai-Sun; Fan, Jiangao; Dufour, Jean-Francois; Papatheodoridis, George; Chen, Li; Schattenberg, Joern M.; Shi, Junping; Xu, Liang; Wong, Grace Lai-Hung; Lange, Naomi F.; Papatheodoridi, Margarita; Mi, Yuqiang; Zhou, Yujie; Byrne, Christopher D.; Targher, Giovanni; Feng, Gong; Zheng, Minghua (2023). Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study, CHINESE MEDICAL JOURNAL. 136(3), 341-350. doi:10.1097/CM9.0000000000002603
  44. Zhang, Xinrong; Yip, Terry Cheuk-Fung; Wong, Grace Lai-Hung; Leow, Wei-Xuan; Liang, Lilian Yan; Lim, Lee-Ling; Li, Guanlin; Ibrahim, Luqman; Lin, Huapeng; Lai, Jimmy Che To; Chim, Angel Mei-Ling; Chan, Henry Lik Yuen; Kong, Alice Pik-Shan; Chan, Wah Kheong; Wong, Vincent Wai-Sun (2023). Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial, GUT. . doi:10.1136/gutjnl-2023-330269
  45. Zhou, Xiao-Dong; Targher, Giovanni; Byrne, Christopher D.; Somers, Virend; Kim, Seung Up; Chahal, C. Anwar A.; Wong, Vincent Wai-Sun; Cai, Jingjing; Shapiro, Michael D.; Eslam, Mohammed; Steg, Philippe Gabriel; Sung, Ki-Chul; Misra, Anoop; Li, Jian-Jun; Brotons, Carlos; Huang, Yuli; Papatheodoridis, George V.; Sun, Aijun; Yilmaz, Yusuf; Chan, Wah Kheong; Huang, Hui; Mendez-Sanchez, Nahum; Alqahtani, Saleh A.; Cortez-Pinto, Helena; Lip, Gregory Y. H.; de Knegt, Robert J.; Ocama, Ponsiano; Romero-Gomez, Manuel; Fudim, Marat; Sebastiani, Giada; Son, Jang Won; Ryan, John D.; Ikonomidis, Ignatios; Treeprasertsuk, Sombat; Pastori, Daniele; Lupsor-Platon, Monica; Tilg, Herbert; Ghazinyan, Hasmik; Boursier, Jerome; Hamaguchi, Masahide; Nguyen, Mindie H.; Fan, Jian-Gao; Goh, George Boon-Bee; Al Mahtab, Mamun; Hamid, Saeed; Perera, Nilanka; George, Jacob; Zheng, Ming-Hua (2023). An international multidisciplinary consensus statement on MAFLD and the risk of CVD, HEPATOLOGY INTERNATIONAL. . doi:10.1007/s12072-023-10543-8
  46. Zulkufli, Nada Syazana; Sthaneshwar, Pavai; Chan, Wah-Kheong (2023). Calculated parameters for the diagnosis of Wilson disease, SINGAPORE MEDICAL JOURNAL. 64(3), 188-195. doi:10.11622/smedj.2022019
  47. Chan, Wah-Kheong; Tan, Soek-Siam; Chan, Siew-Pheng; Lee, Yeong-Yeh; Tee, Hoi-Poh; Mahadeva, Sanjiv; Goh, Khean-Lee; Ramli, Anis Safura; Mustapha, Feisul; Kosai, Nik Ritza; Raja Ali, Raja Affendi (2022). Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 37(5), 795-811. doi:10.1111/jgh.15787
  48. Chan, Wah-Kheong; Wong, Vincent W. -S. (2022). Meaning of non-overlapping patients between the MAFLD and NAFLD definitions, LIVER INTERNATIONAL. 42(2), 271-273. doi:10.1111/liv.15142
  49. Leung, Howard Ho-Wai; Puspanathan, Pavitratha; Chan, Anthony Wing-Hung; Mustapha, Nik Raihan Nik; Wong, Vincent Wai-Sun; Chan, Wah-Kheong (2022). Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. . doi:10.1111/jgh.15843
  50. Lim, Sze Zee; Chuah, Kee Huat; Rajaram, Ruveena Bhavani; Stanley, Khoo; Shahrani, Shahreedhan; Chan, Wah Kheong; Ho, Shiaw Hooi; Hilmi, Ida Normiha; Goh, Khean Lee; Mahadeva, Sanjiv (2022). Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. . doi:10.1111/jgh.15905
  51. Mendez-Sanchez, Nahum; Bugianesi, Elisabetta; Gish, Robert G.; Lammert, Frank; Tilg, Herbert; Nguyen, Mindie H.; Sarin, Shiv K.; Fabrellas, Nuria; Zelber-Sagi, Shira; Fan, Jian-Gao; Shiha, Gamal; Targher, Giovanni; Zheng, Ming-Hua; Chan, Wah-Kheong; Vinker, Shlomo; Kawaguchi, Takumi; Castera, Laurent; Yilmaz, Yusuf; Korenjak, Marko; Spearman, C. Wendy; Ungan, Mehmet; Palmer, Melissa; El-Shabrawi, Mortada; Gruss, Hans-Juergen; Dufour, Jean-Francois; Dhawan, Anil; Wedemeyer, Heiner; George, Jacob; Valenti, Luca; Fouad, Yasser; Romero-Gomez, Manuel; Eslam, Mohammed (2022). Global multi-stakeholder endorsement of the MAFLD definition, LANCET GASTROENTEROLOGY & HEPATOLOGY. 7(5), 388-390. doi:10.1016/S2468-1253(22)00062-0
  52. Prasoppokakorn, Thaninee; Chan, Wah-Kheong; Wong, Vincent Wai-Sun; Pitisuttithum, Panyavee; Mahadeva, Sanjiv; Mustapha, Nik Raihan Nik; Wong, Grace Lai-Hung; Leung, Howard Ho-Wai; Sripongpun, Pimsiri; Treeprasertsuk, Sombat (2022). Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease, WORLD JOURNAL OF GASTROENTEROLOGY. 28(15), 1563-1573. doi:10.3748/wjg.v28.i15.1563
  53. Wong, Wei-Kei; Chan, Wah-Kheong; Ganapathy, Shubash Shander; Lim, Soo-Kun (2022). Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia, SEMINARS IN DIALYSIS. . doi:10.1111/sdi.13117
  54. Yip, Terry Cheuk-Fung; Lee, Hye Won; Chan, Wah Kheong; Wong, Grace Lai-Hung; Wong, Vincent Wai-Sun (2022). Asian perspective on NAFLD-associated HCC, JOURNAL OF HEPATOLOGY. 76(3), 726-734. doi:10.1016/j.jhep.2021.09.024
  55. Younossi, Zobair M.; Ong, Janus P.; Takahashi, Hirokazu; Yilmaz, Yusuf; Hi, Yuichiro Eguc; El Kassas, Mohamed; Buti, Maria; Diago, Moises; Zheng, Ming-Hua; Fan, Jian-Gao; Yu, Ming-Lung; Wong, Vincent Wai-Sun; Alswat, Khalid; Chan, Wah-Kheong; Mendez-Sanchez, Nahum; Burra, Patrizia; Bugianesi, Elisabetta; Duseja, Ajay K.; George, Jacob; Papatheodoridis, George, V; Saeed, Hamid; Castera, Laurent; Arrese, Marco; Kugelmas, Marcelo; Romero-Gomez, Manuel; Alqahtani, Saleh; Ziayee, Mariam; Lam, Brian; Younossi, Issah; Racila, Andrei; Henry, Linda; Stepanova, Maria (2022). A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 20(6), E1456-E1468. doi:10.1016/j.cgh.2021.06.048
  56. Younossi, Zobair M.; Yilmaz, Yusuf; El-Kassas, Mohamed; Duseja, Ajay; Hamid, Saeed; Esmat, Gamal; Mendez-Sanchez, Nahum; Chan, Wah Kheong; Singal, Ashwani K.; Lam, Brian; Felix, Sean; Younossi, Elena; Verma, Manisha; Price, Jillian K.; Nader, Fatema; Younossi, Issah; Racila, Andrei; Stepanova, Maria (2022). The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry, HEPATOLOGY COMMUNICATIONS. . doi:10.1002/hep4.2048
  57. Younossi, Zobair M.; Yu, Ming-Lung; El-Kassas, Mohamed; Esmat, Gamal; Fernandez, Marlen I. Castellanos; Buti, Maria; Papatheodoridis, Georgios; Yilmaz, Yusuf; Isakov, Vasily; Duseja, Ajay; Mendez-Sanchez, Nahum; Hamid, Saeed; Gordon, Stuart C.; Romero-Gomez, Manuel; Chan, Wah-Kheong; Ong, Janus P.; Younossi, Issah; Lam, Brain; Ziayee, Mariam; Nader, Fatema; Racila, Andrei; Henry, Linda; Stepanova, Maria (2022). Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry, JOURNAL OF VIRAL HEPATITIS. . doi:10.1111/jvh.13741
  58. Andrieux-Meyer, I., Tan, S. S., Thanprasertsuk, S., Salvadori, N., Menetrey, C., Simon, F., . . . Murad, S. (2021). Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial. Lancet Gastroenterology & Hepatology, 6(6), 448-458. doi: 10.1016/s2468-1253(21)00031-5
  59. Ng, Y. Z., Lai, L. L., Wong, S. W., Mohamad, S. Y., Chuah, K. H., & Chan, W. K. (2021). Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease. Plos One, 16(5), 13. doi: 10.1371/journal.pone.0250300
  60. Petroff, D., Blank, V., Newsome, P. N., Shalimar, Voican, C. S., Thiele, M., . . . Karlas, T. (2021). Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterology & Hepatology, 6(3), 185-198. doi: 10.1016/s2468-1253(20)30357-5
  61. Sang, C., Yan, H. M., Chan, W. K., Zhu, X. P., Sun, T., Chang, X. X., . . . Xie, G. X. (2021). Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. Frontiers in Medicine, 8, 10. doi: 10.3389/fmed.2021.637652
  62. Tan, E. Z. Y., Lai, L. L., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., & Chan, W. K. (2021). Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus. Journal of Gastroenterology and Hepatology, 36(3), 751-757. doi: 10.1111/jgh.15160
  63. Ting, Y. W., Kong, A. S. Y., Zain, S. M., Chan, W. K., Tan, H. L., Mohamed, Z., . . . Mohamed, R. (2021). Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort. Clinical and Molecular Hepatology, 27(3), 486-498. doi: 10.3350/cmh.2020.0162
  64. Wong, W. K., & Chan, W. K. (2021). Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics, 43(3), 473-499. doi: 10.1016/j.clinthera.2021.01.007
  65. Zhou, Y. J., Gao, F., Liu, W. Y., Wong, G. L. H., Mahadeva, S., Mustapha, N. R. N., . . . Zheng, M. H. (2021). Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics, 54(4), 470-480. doi: 10.1111/apt.16487
  66. Adams, L. A., & Chan, W. K. (2020). Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future. Seminars in Liver Disease, 40(04), 331-338. doi: 10.1055/s-0040-1713006
  67. Chan, T. T., Chan, W. K., Wong, G. L. H., Chan, A. W. H., Mustapha, N. R. N., Chan, S. L., . . . Wong, V. W. S. (2020). Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology, 115(6), 867-875. doi: 10.14309/ajg.0000000000000588
  68. Chong, C. C. N., Lakhtakia, S., Nguyen, N., Hara, K., Chan, W. K., Puri, R., . . . Teoh, A. Y. B. (2020). Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial. Endoscopy, 52(10), 856-863. doi: 10.1055/a-1172-6027
  69. Chuah, K. H., Lai, L. L., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., & Chan, W. K. (2020). Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one. Journal of Gastroenterology and Hepatology, 35(8), 1404-1411. doi: 10.1111/jgh.14978
  70. Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., . . . George, J. (2020). A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. Journal of Hepatology, 73(1), 202-209. doi: 10.1016/j.jhep.2020.03.039
  71. Eslam, M., Sarin, S. K., Wong, V. W. S., Fan, J. G., Kawaguchi, T., Ahn, S. H., . . . George, J. (2020). The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International, 14(6), 889-919. doi: 10.1007/s12072-020-10094-2
  72. Gao, F., Huang, J. F., Zheng, K. I., Pan, X. Y., Ma, H. L., Liu, W. Y., . . . Zheng, M. H. (2020). Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 35(10), 1804-1812. doi: 10.1111/jgh.15055
  73. Harry, S., Lai, L. L., Mustapha, N. R. N., Aziz, Y. F. A., Vijayananthan, A., Rahmat, K., . . . Chan, W. K. (2020). Volumetric Liver Fat Fraction Determines Grade of Steatosis More Accurately Than Controlled Attenuation Parameter in Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology, 18(4), 945-+. doi: 10.1016/j.cgh.2019.08.023
  74. Khoo, S., Wong, V. W. S., Goh, G. B. B., Fan, J. G., Chan, W. K., Seto, W. K., Chow, W. C. (2020). Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 35(2), 320-325. doi: 10.1111/jgh.14794
  75. Lai, L. L., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., Chan, W. K. (2020). Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus. Digestive Diseases and Sciences, 65(2), 623-631. doi: 10.1007/s10620-019-5477-1
  76. Lai, Lee-Lee; Vethakkan, Shireene Ratna; Nik Mustapha, Nik Raihan; Mahadeva, Sanjiv; Chan, Wah-Kheong (2020). Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus, DIGESTIVE DISEASES AND SCIENCES. 65(2), 623-631. doi:10.1007/s10620-019-5477-1
  77. Leong, W. L., Lai, L. L., Mustapha, N. R. N., Vijayananthan, A., Rahmat, K., Mahadeva, S., Chan, W. K. (2020). Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 35(1), 135-141. doi: 10.1111/jgh.14782
  78. Leong, Wai Ling; Lai, Lee Lee; Mustapha, Nik Raihan Nik; Vijayananthan, Anushya; Rahmat, Kartini; Mahadeva, Sanjiv; Chan, Wah Kheong (2020). Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 35(1), 135-141. doi:10.1111/jgh.14782
  79. Newsome, P. N., Sasso, M., Deeks, J. J., Paredes, A., Boursier, J., Chan, W. K., . . . Harrison, S. A. (2020). FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterology Hepatology, 5(4), 362-373. doi: 10.1016/s2468-1253(19)30383-8
  80. Newsome, Philip N.; Sasso, Magali; Deeks, Jonathan J.; Paredes, Angelo; Boursier, Jerome; Chan, Wah-Kheong; Yilmaz, Yusuf; Czernichow, Sebastien; Zheng, Ming-Hua; Wong, Vincent Wai-Sun; Allison, Michael; Tsochatzis, Emmanuel; Anstee, Quentin M.; Sheridan, David A.; Eddowes, Peter J.; Guha, Indra N.; Cobbold, Jeremy F.; Paradis, Valerie; Bedossa, Pierre; Miette, Veronique; Fournier-Poizat, Celine; Sandrin, Laurent; Harrison, Stephen A. (2020). FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study, LANCET GASTROENTEROLOGY & HEPATOLOGY. 5(4), 362-373. doi:10.1016/S2468-1253(19)30383-8
  81. Pitisuttithum, P., Chan, W. K., Goh, G. B. B., Fan, J. G., Song, M. J., Charatcharoenwitthaya, P., . . . Treeprasertsuk, S. (2020). Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative. World Journal of Gastroenterology, 26(19), 2416-2426. doi: 10.3748/wjg.v26.i19.2416
  82. Pitisuttithum, P., Chan, W. K., Piyachaturawat, P., Imajo, K., Nakajima, A., Seki, Y., . . . Treeprasertsuk, S. (2020). Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. Bmc Gastroenterology, 20(1), 9. doi: 10.1186/s12876-020-01240-z
  83. Pitisuttithum, Panyavee; Chan, Wah Kheong; Piyachaturawat, Panida; Imajo, Kento; Nakajima, Atsushi; Seki, Yosuke; Kasama, Kazunori; Kakizaki, Satoru; Fan, Jian Gao; Song, Myeong Jun; Yoon, Seung Kew; Dan, Yock Young; Lesmana, Laurentius; Ho, Khek Yu; Goh, Khean Lee; Wong, Vincent Wai Sun; Treeprasertsuk, Sombat (2020). Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study, BMC GASTROENTEROLOGY. 20(1). doi:10.1186/s12876-020-01240-z
  84. Tan, H. L., Zain, S. M., Eng, H. S., Mohamed, Z., Mahadeva, S., Chan, W. K., . . . Mohamed, R. (2020). Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease. Hepatology Research, 50(8), 947-954. doi: 10.1111/hepr.13525
  85. Wong, G. L. H., Wong, V. W. S., Thompson, A., Jia, J. D., Hou, J. L., Lesmana, C. R. A., . . . Asia-Pacific Working Grp, L. (2020). Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterology & Hepatology, 5(8), 776-787. doi: 10.1016/s2468-1253(20)30190-4
  86. Wong, S. W., Chan, W. K., & Mohamed, R. (2020). Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B. Journal of Viral Hepatitis, 27(12), 1297-1305. doi: 10.1111/jvh.13361
  87. Zhang, X. R., Goh, G. B. B., Chan, W. K., Wong, G. L. H., Fan, J. G., Seto, W. K., . . . Wong, V. W. S. (2020). Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease. Liver International, 40(11), 2719-2731. doi: 10.1111/liv.14638
  88. Chan, W. K., Treeprasertsuk, S., Goh, G. B. B., Fan, J. G., Song, M. J., Charatcharoenwitthaya, P., . . . Wong, V. W. S. (2019). Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis. Clinical Gastroenterology and Hepatology, 17(12), 2570-+. doi:10.1016/j.cgh.2019.03.006
ESCI
  1. Raj, S. Vishnu; Ismail, Maslinor; Chan, Wah-Kheong; Majid, Hazreen Abdul (2023). A systematic review on factors associated with non-alcoholic fatty liver disease (NAFLD) among adolescents, CLINICAL NUTRITION ESPEN. 57, 131-137. doi:10.1016/j.clnesp.2023.06.014
Scopus
  1. Karuthan, S. R., Koh, P. S., Chinna, K., & Chan, W. K. (2021). Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients. The Medical journal of Malaysia, 76(2), 199-204.
  2. Sang, C., Yan, H., Chan, W. K., Zhu, X., Sun, T., Chang, X., . . . Xie, G. (2021). Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. Frontiers in Medicine, 8. doi: 10.3389/fmed.2021.637652
Others
  1. Karuthan SR, Koh PS, Chinna K, Chan WK. Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients. Med J Malaysia. 2021 Mar;76(2):199-204. PMID: 33742628.
  2. M zes, F. E., Lee, J. A., Selvaraj, E. A., Jayaswal, A. N. A., Trauner, M., Boursier, J., ... & Pavlides, M. (2021). Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut.
  3. Chuah, K. H., Lai, L. L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., and Chan, W. K. ( 2020) Liver stiffness measurement in non alcoholic fatty liver disease: two is better than one. Journal of Gastroenterology and Hepatology, https://doi.org/10.1111/jgh.14978.
  4. Eslam, M., Newsome, P. N., Anstee, Q. M., Targher, G., Gomez, M. R., Zelber-Segi, S et al. (2020). A new definition for metabolic associated fatty liver disease :an international expert consensus statement. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2020.03.039.
  5. Gao, F., Huang, J. F., Zheng, K. I., Pan, X. Y., Ma, H. L., Liu, W. Y et al. (2020). Development and validation of a novel non-invasive test for diagnosing fibrotic NASH in patients with biopsy-proven NAFLD. J Gastroenterol Hepatol. https://doi.org/10.1111/jgh.15055.
  6. Tan, E. Z-Y., Lai, L.L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., Chan, W-K . (in press). Modest alcohol intake is not associated with significant hepatic steatosis nor more severe liver disease in patient with diabetes mellitus. J Gastroen Hepatol.
  7. Tan, H. L., Zain, S. M., Eng, H. S., Mohamed, Z., Mahadeva, S., Chan, W. K., ... & Mohamed, R. (2020). Allele HLA DQB1* 06 reduces fibrosis score in patients with non alcoholic fatty liver disease. Hepatology Research, 50(8), 947-954.
  8. Wong, S.W and Chan, W.K (2020). Epidemiology of non-alcoholic fatty liver disease in Asia Indian Journal of Gastroenterology. Indian Journal of Gastroenterology.
  9. Yilmaz, Y., Yu, M. L., Lam, B. P., Ferret, M. A. B., Papatheodoridis, G., Chan Sr, W. K., ... & Isakov, V. A. (2020). The impact of chronic Hepatitis B on patient-reported outcomes from The Global Liver Registry . [Abstract]. Hepatology, 72, 471A-471A.
  10. Younossi, Z. M., Yilmaz, Y., Yu, M. L., Wong, V. W. S., Castellanos Fernandez, M., Isakov, V. A., ... & Bugianesi, E. (2020). Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH Registry [Abstract]. Hepatology, 72, 426A-427A.
  11. Younossi, Z., Yilmaz, Y., El Kassas, M., Wong, V. W. S., Duseja, A. K., M ndez-Sanchez, N., ... & Alswat, K. (2020). Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians. [Abstract]. Hepatology, 73, S440.
  12. Yu, M. L., El Kassas Sr, M., Lam, B. P., Esmat, G., Femandez, M. C., Ferret, M. A. B., ... & Gordon, S. C. (2020). Patient-reported outcomes in patients with chronic Hepatitis C: data from The Global Liver Registry . [Abstract]. Hepatology, 72, 598A-599A.
  13. Zain, S. M., Tan, H. L., Mohamed, Z., Chan, W. K., Mahadeva, S., Basu, R. C., & Mohamed, R. (2020). Use of simple scoring systems for a public health approach in the management of non alcoholic fatty liver disease patients. JGH Open, 4(6), 1155-1161.
  14. Zhang, X., Goh, G. B. B., Chan, W. K., Wong, G. L. H., Fan, J. G., Seto, W. K., ... & Kim, S. U. (2020). Unhealthy lifestyle habits and physical inactivity among Asian patients with non alcoholic fatty liver disease. Liver International, 40(11), 2719-2731.
  15. Chan WK, Treeprasertsuk S, Goh GB, Fan JG, Song MJ, Charatcharoenwitthaya P, Duseja A, Dan YY, Imajo K, Nakajima A, Ho KY, Goh KL, Wong VW. Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis. Clin Gastroenterol Hepatol 2019, in press.
  16. Chan WK, Wong VW. A new bile acid treatment for non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol 2019, in press.
  17. Chuah KH, Chan WK. Reply to: CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis. Liver Int 2019, in press.
  18. Chuah KH, Wan Yusoff WNI, Sthaneshwar P, Nik Mustapha NR, Mahadeva S, Chan WK. MACK-3 (Combination of hoMa, Ast, CK18): a promising novel biomarker for fibrotic non-alcoholic steatohepatitis. Liver Int 2019, in press.
  19. Chuah, K., Chan, W. Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance. Curr Hepatology Rep 18, 492 502 (2019) doi:10.1007/s11901-019-00493-x
  20. Fu, C., Wai, J.W., Nik Mustapha, N.R., Irles, M., Lai-Hung Wong, G., Mahadeva, S., Shili, S., Wing-Hung Chan, A., Merrouche, W., Lik-Yuen Chan, H., Foucher, J., Le Bail, B., Wai-Sun Wong, V., Chan, W.K., de L dinghen, V. Performance of simple fibrosis scores in non-obese patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology (2019), doi: https://doi.org/10.1016/j.cgh.2019.09.027.
  21. Harry, S., Lee, L. L., Nik Mustapha, N.R., Abdul Aziz, Y.F., Vijayananthan, A., Rahmat, K., Mahadeva, S., Chan, W.K. (in press). Volumetric liver fat fraction determines grade of steatosis more accurately than controlled attenuation parameter in patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology (2019). doi: https://doi.org/10.1016/j.cgh.2019.08.023.
  22. Jayaraman, T., Lee, Y.Y., Chan, W.K., and Mahadeva, S. Epidemiological differences of common liver conditions between Asia and the West. Journal of Gastroenterology and Hepatology. (2019), doi: 10.1002/jgh3.12275.
  23. Kamarajah SK, Khoo S, Chan WK, Sthaneshwar P, Nik Mustapha NR, Mahadeva S. Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis. JGH Open 2019, in press.
  24. Khoo S, Wong VW, Goh GB, Fan JG, Chan WK, Seto WK, Chow WC. Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2019, in press.
  25. Lai LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK. Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus. Dig Dis Sci 2019, in press.
  26. Leong WL, Lai LL, Nik Mustapha NR, Vijayananthan A, Rahmat K, Mahadeva S, Chan WK. Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2019, in press
  27. Wong VW, Irles M, Wong GL, Shili S, Chan AW, Merrouche W, Shu SS, Foucher J, Le Bail B, Chan WK, Chan HL, de Ledinghen V. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut 2019, in press.
  28. Chan WK, Dan YY, Wong VWS, for the GO ASIA Initiative. (2018). Editorial: NAFLD in Asia clinical associations with advanced disease become clearer Authors reply. Aliment Pharmacol Ther, in press.
  29. Chan WK, Nik Mustapha NR, Mahadeva S, Wong VW, Cheng JY, Wong GL. Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis? J Gastroenterol Hepatol 2018;33:1787-1795
  30. Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VW. Clinical features and treatment of non-alcoholic fatty liver disease across the Asia Pacific region the GO ASIA initiative. Aliment Pharmacol Ther 2018, in press.
  31. Chan WK, Yeoh KY, Lim CY, Lai SM, Lee JY, Leow AHR, Goh KL.(in press) Hepatitis B virus infection among children of hepatitis B surface antigen positive mothers in a Malaysian hospital. Med J Malaysia.
  32. Kamarajah, S.K., Chan, WK., Nik Mustapha, N.R. et al., (2018) Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease. Hepatol Int.
  33. Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JP, Sarin SK, Badea R, Lee HW, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Impact of Controlled Attenuation Parameter on Detecting Fibrosis using Liver Stiffness Measurement. Aliment Pharmacol Ther 2018, in press.
  34. Khoo, S., Chan, W.K., & Mahadeva, S. (2018). Endoscopic management of colonoscopy-related perforation. Journal of Digestive Endoscopy, 9(20),47-52.
  35. Lai, L.L., Wan Yusoff, W.N.I., Vethakkan, S.R., Nik Mustapha, N.R., Chan W.K., (2018).Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. Journal of Gastroenterology and Hepatology. doi:10.1111/jgh.14577
  36. Tan, E. C., Tai, M. S., Chan, W., & Mahadeva, S. (2018). Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community. JGH Open, 1-9. doi:10.1002/jgh3.12114
  37. Wong SW, Ting YW, Chan WK. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications. JGH Open 2018, 1-7.
  38. Chan WK, Nik Mustapha NR, Wong GL, Wong VW, Mahadeva S. Controlled attenuation parameter using Fibroscan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population, UEG Journal 2017; 5(1): 76-85.
  39. Huiyan L, Chan WK, Neto MG. Endoscopic sleeve gastroplasty: case report, technique and literature review. J Dig Dis 2017, in press.
  40. Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wai-Sun Wong V, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Sik Jung K, Marcellin P, Filice C, Mahadeva S, Lai-Hung Wong G, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Individual Patient Data Meta-Analysis of Controlled Attenuation Parameter (CAP) Technology for Assessing Steatosis. J Hepatol 2017, 66(5): 1022-1030.
  41. Lee-Lee Lai, Wah-Kheong Chan, Pavai Sithaneshwar, Nik Raihan Nik Mustapha, Khean-Lee Goh & Sanjiv Mahadeva (2017) Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease. PLoS ONE 12(4): e0174982.
  42. Say-Yee Loo, Wah-Kheong Chan. Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr 2017. doi: 10.21037/hbsn.2017.03.06
  43. Wah Kheong C, Nik Mustapha NR, Mahadeva S. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2017;15(12):1940-9 e8.
  44. Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol 2017, in press
  45. Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2: Management and special groups. J Gastroenterol Hepatol 2017, in press.
  46. Ahmad Najib Azmi, Wah-Kheong Chan, Sanjiv Mahadeva, Khean-Lee Goh. Split-dose low volume bowel preparation, a feasible option for preparation for colonoscopy. Endoscopy 2016; 48(2): 197.
  47. Chan WK, Wong VW. Oxidized low-density lipoprotein in non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2016; 31(9): 1516-18.
  48. Chee-Chiat Liong, Sarala Ravindran, Gnana Kumar Gnanasuntharam, Edmund Fui-Min Chin, Peng-Soon Koh, Wah-Kheong Chan. Enteropathy-associated T-cell lymphoma: an extremely rare cause of chronic diarrhoea. Med J Malaysia 2016; 71(2): 88-90.
  49. Jianyi Calvin Koh, Wai Mun Loo, Khean-Lee Goh, Kentaro Sugano, Wah-Kheong Chan, Wai-Yan Philip Chiu, Myung-Gyu Choi, Sutep Gonlachanvit, Wei-Jei Lee, Wei-Jie Jonathan Lee, Yeong Yeh Lee, Laurentius A Lesmana, You-Ming Li, Chun-Jen Liu, Bunzo Matsuura, Atsushi Nakajima, Enders Kwok Wai Ng, Jose D Sollano, Simon Kin-Hung Wong, Vincent Wai-Sun Wong, Yunsheng Yang, Khek-Yu Ho, Yock-Young Dan. Asian Consensus on the Relationship between Obesity and Gastrointestinal and Liver Diseases. J Gastroenterol Hepatol 2016; 31(8): 1405-13.
  50. Ahmad Najib Azmi, Wah-Kheong Chan, Khean-Lee Goh. Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy. J Dig Dis. 2015; 16(9): 537-40.
  51. Rajvinder Singh, Mahesh Jayanna, Jennie Wong, Lee Guan Lim, Jun Zhang, Jing Lv, Dong Liu, Yi-Chia Lee, Ming-Lun Han, Ping-Huei Tseng, Vikneswaran Namasivayam, Rupa Banerjee, Noriya Uedo,Wah Kheong Chan, Shiaw Hooi Ho, Shi-yao Chen, Shobna Bhatia, Kohei Funasaka, Takafumi Ando, Justin Wu, Cosmas Lesmana, William Tam, Wen-Lun Wang, Chi-Yang Chang, Hwoon-Yong Jung, Kee Wook Jung, Muhammad Begawan Bestari, Kenshi Yao, Vui Heng Chong, Prateek Sharma, Khek-Yu Ho. Narrow-band imaging and white- light endoscopy with optical magnification in the diagnosis of dysplasia in Barrett s esophagus: results of the Asia-Pacific Barrett s Consortium. Endoscopy International Open. 2015; 3(1): E14-8.
  52. Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver dis-ease in centrally obese but not in non-centrally obese patients with diabetes mellitus. Asia Pac J Clin Nutr. 2015; 24(2): 289-98.
  53. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatol Int. 2015; 9(4): 594-602.
  54. Zain SM, Mohamed Z, Pirmohamed M, Tan HL, Alshawsh MA, Mahadeva S, Chan WK, Mustapha NR, Mohamed R. Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non- alcoholic fatty liver disease. Sci Rep. 2015; 5: 13306.
  55. Chan W. K., Najib Azmi, Mahadeva S., Goh K. L. (2014). Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopy. World J Gastroenterol. 2014; 20(39): 14488-94.
  56. Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography- diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. Clin Res Hepatol Gastroenterol. 2014; 38(3): 284-91.
  57. Wah-Kheong Chan, Ida Normiha Hilmi, Phaik-Leng Cheah, Khean-Lee Goh. Progression of non-alcoholic fatty liver disease - a prospective clinicopathological follow-up study. J Dig Dis. 2014; 15(10): 545-52.
  58. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2014; 29(7): 1470-6.
  59. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. PLoS One. 2014; 9(9): e105903.
  60. Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sithaneshwar, Khean-Lee Goh. Non-alcoholic fatty liver disease in a young multiracial Asian population - a worrying ethnic predilection in Malay and Indian males. Hepatol Int. 2013; 8(1); 121-7.
  61. Zain SM, Rosmawati M, Cooper D, Razali R, Rampal S, Mahadeva S, Chan WK, Anwar A, Nurul SMR, Anis SF, Cheah PL, Basu RC, Tan HL, Mohamed Z. Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non- alcoholic fatty liver disease. PLOS ONE 2014;9 (4):e95604 , PLOS ONE 9(4):E95604 APRIL 2014. Impact Factor: 3.53. DOI: 10.1371/journal.pone.0095604
  62. Chan WK, Roslani AC, Law CW, Goh KL, Mahadeva S. 2013. Clinical outcomes and direct costing of endoluminal clipping compared to surgery in the management of iatrogenic colonic perforation. J Dig Dis. 2013; 14(12):670-5. doi: 10.1111/1751-2980.12097
  63. Wah-Kheong Chan, Alexander Tong-Boon Tan, Vethakkan Shireene Ratna, Pei-Chien Tah, Vijayananthan Anushya, Khean-Lee Goh. Non-Alcoholic Fatty Liver Disease (NAFLD) in Diabetics Prevalence and Predictive Factors in a Multi-Racial Hospital Clinic Population in Malaysia. J Gastroenterol Hepatol 2013, 28 (8): 1375 - 83.
  64. Wah-Kheong Chan, Khean-Lee Goh. Epidemiology of a Fast-Emerging Disease in the Asia Pacific Region - Non-Alcoholic Fatty Liver Disease (NAFLD). Hepatol Int. 2013; 7(1): 65-71.
  65. Khean-Lee Goh, Wah-Kheong Chan. Commentary: changing aetiology of peptic ulcers. Alimentary Pharmacology and Therapeutics 2012.
  66. Najib Azmi, Wah-Kheong Chan, Khean-Lee Goh. Evaluation of patient satisfaction of an outpatient gastroscopy service in an Asian tertiary care hospital. BMC Gastroenterology 2012, 12:96.
  67. Wah-Kheong Chan, Jaganathan Vijayasangkar, Sanjiv Mahadeva. Cyclosporine Rescue Therapy in Autoimmune Liver Cirrhosis: A Case Report. Turkish Journal of Gastroenterology 2012.
  68. Wah-Kheong Chan, Khean-Lee Goh. Evaluation of Patient Satisfaction of an Outpatient Colonoscopy Service in an Asian Tertiary Care Hospital. Gastroenterology Research and Practice 2012.
  69. Khean-Lee Goh, Wah-Kheong Chan, Seiji Shiota, Yoshio Yamaoka. 2011. Epidemiology of Helicobacter pylori Infection and Public Health Implications. Helicobacter 16: 1 9.
  70. Sanjiv Mahadeva, Wah-Kheong Chan, Mohammed Mohazmi, Ramanujam Sujarita, Khean-Lee Goh. A validation study of the Leeds Dyspepsia Questionnaire in a multi-ethnic Asian population. J Gastroenterol Hepatol. 2011 Jun 8. doi: 10.1111/j.1440-1746.2011.06806.x. [Epub ahead of print]
  71. Wah-Kheong Chan, Arjunan Saravanan, Jeeta Manikam, Khean-Lee Goh, Sanjiv Mahadeva. Appointment waiting times and education level influence the quality of bowel preparation in adult patients undergoing colonoscopy. BMC Gastroenterol 2011. Jul 28;11:86.
Article in Proceeding
  1. LS Zee, CK Huat, B Ruveena, K Stanley, S Shahreedhan, CW Kheong, HS Hooi, M Rosmawati, H Ida, GK Lee, M Sanjiv. The spectrum of gastrointestinal and liver diseases has an ethnic predilection: observations from a specialist clinic in Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 40
  2. Mozes, F., Lee, J., Selvaraj, E., Jayaswal, A., Trauner, M., Boursier, J., ... & Pavlides, M. (2021, July). Individual patient data meta-analysis of the diagnostic performance of single and sequentially combined non-invasive tests in detecting advanced fibrosis. In JOURNAL OF HEPATOLOGY (Vol. 75, pp. S259-S260). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
  3. Tan SS, Mohd Said HRH, Abu Hassan MR, Omar H, Tee HP, Chan WK, Kumar S, Mustafa M, Md Salleh MF, Adnan SD, Thongsawat S, Thetket K, Avihingsanon A, Khemnark S, Salvadori N, Brachet L. Concordance between Fibroscan and aspartate aminotransferase-to-platelet ratio index (APRI) using different cut-off values in 603 Asian adults with chronic hepatitis C virus (HCV) with no or compensated cirrhosis in Thailand and Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 259.
  4. Wong WK, Lim SK, Ganapathy S, Chan WK. Metabolic-dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiracial urban population in Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 49.
  5. Younossi, Z., Harrison, S., Newsome, P. N., Chan, W. K., Yilmaz, Y., de Ledinghen, V., ... & Sanyal, A. (2021, July). Development and validation of Agile 3+: novel FibroScan based score for the diagnosis of advanced fibrosis in patients with nonalcoholic fatty liver disease. In JOURNAL OF HEPATOLOGY (Vol. 75, pp. S257-S257). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
  6. Younossi, Z., Yilmaz, Y., El-Kassas, M., Duseja, A. K., Hamid, S. S., Esmat, G., ... & Stepanova, M. (2021, July). The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry. In Journal of Hepatology (Vol. 75, pp. S655-S655). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
  7. Tan S.S., Mohd. Said R., Abu Hassan M.R., Omar H., Tee H.P., Chan W.K., et al. (2020, December 4-5). Concordance between FibroScan and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia [Poster presentation]. International Viral Hepatitis Elimination Meeting (IVHEM) 2020. https://dndi.org/events/2020/international-viral-hepatitis-elimination-meeting-ivhem-2020/.
  8. Chuah K.H., Lai L.L., Vethakkan S.R.,Nik Mustapha N.R., Mahadeva S., & Chan W.K. (2019). Liver stiffness measurement in non-alcoholic fatty liver disease: two is better than one. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019.
  9. Chuah K.H., Wan Yusoff W.N.I., Sthaneshwar P., Nik Mustaffa N.R., Mahadeva S., & Chan W.K. (2019). MACK-3 (Combination of HOMA, AST, CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019.
  10. Khoo S, Wong VW, Goh GB, Fan JG, Chan WK, Seto WK, Chow WC. Prescription of statin and treatment targets in non-alcoholic fatty liver disease patients. Hepatol Int 2019; 13(Suppl 1): S196.
  11. Khoo S., Sun Wong V.W., Bee Goh G.B., Fan J., Chan W.K., Seto W.K., & Chow W.C. (2019). Prescription of Statin and Low-Density Lipoprotein Cholestrol Treatment Targets in Non-Alcoholic Fatty Liver Disease Petients. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019.
  12. Lee C.C., Alex H.R., & Chan W.K. (2019). Fibroscan as a Non-Invasive Approach to Predict the Presence and Size of Varices in the Malaysian Cirrhotic Population. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019.
  13. Tan H.L., Shahrani S., Mohd. Zain S., Mohamed Z., Chan W.K., Mahadeva S., & Mohamed R. (2019). Non-Invasive Scoring Systems for the Diagnosis of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD) in a Malaysian Cahort. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019.
  14. Andrieux-Meyer,I.,Tan, S-S., Salvadori,N., Simon, F., Cressey, T.R., Said,H.R.H.M.A.,... & Murad, S. (2018).Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotype 1,2,3,and 6 The STORM-C-1 phase IIIII trial. Journal of Hepatology, 68 (1),S123. https://doi.org/10.1016/S0168-8278(18)30428-8
  15. Chan, W.K (2018) Current Therapies - What Has Promise? What Does Not?. Annual Scientific Meeting of MSGH (GUT2018), 41
  16. Charing Chong, Sundeep Lakhtakia, Kazuo Hara et al.(2018) Macroscopic On-site Quality Evaluation (MOSE) of Biopsy Specimens to Improve The Diagnostic Accuracy During EUS-Guided FNA Using a 19G Needle for Solid Lesions: A Prospective Randomized Controlled Study. Proceeding of Gastrointestinal Endoscopy, 87(6), AB319. doi.org/10.1016/j.gie.2018.04.1688
  17. Chung, Y.C., Tan, S.S., Chan, W.K., Chin, K.T., Hoe, C.H., Lee, Y.Y. (2018) Direct Acting Anti-Viral (DAA) in Hepatitis C Virus (HCV) Patients: Early Real-World Data From Malaysia. Annual Scientific Meeting of MSGH (GUT2018). 71
  18. Harry, S., Vijayananthan, A., Chan, W.K., Rahmat, K., Faridah, Y. (2018) A Comparison of the Hepafat-Scan and Fibroscan Controlled Attenuation Parameter in the Estimation of Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease Using Histology as the Reference Standard, Annual Scientific Meeting of MSGH (GUT2018), 85.
  19. House, M., Lai, L.L., Chan, W.K.,Mustapha, N.R.N., Vijayananthan,A., Mahadeva, S., & Pierre, T.S. (2018). A non-invasive biomarker of hepatic inflammation based on magnetic resonance imaging. Journal of Hepatology, 68 (1), S565. https://doi.org/10.1016/S0168-8278(18)31387-4
  20. Lai, L.L., Vethakkan, S. R., Nik Mustapha, N.R., Mahadeva, S., Chan, W.K. (2018) Empagliflozin for the treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus. Annual Scientific Meeting of MSGH (GUT2018), 58
  21. Lai, L.L., Vethakkan, S., Mustapha, N.R.N., Mahadeva, S., Chan, W.K. (2018). A pilot study of empagliflozin for the treatment of non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus. Journal of Hepatology, 68 (1), S110. https://doi.org/10.1016/S0168-8278(18)30428-8
  22. Lai, L.L., Wan Yusoff, W.N.I., Vethakkan, S.R., Nik Mustapha, N.R., Chan W.K., (2018) Screening for Non-alcoholic Fatty Liver Disease and Advance Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Using Controlled Attenuation Parameter and Liver Stiffness Measurements. Annual Scientific Meeting of MSGH (GUT2018). 59
  23. Leong, W.L., Lai, L.L., Nik Mustapha, N.R., Vijayananthan, A., Rahmat, K., Mahadeva, S., Chan, W.K. (2018) Comparing Shear Wave Elastography and Transient Elastography for the Diagnosis of Fibrosis Stages in Patients with Non-alcoholic Fatty Liver Disease Using Liver Biopsy as the Reference Standard. Annual Scientific Meeting of MSGH GUT 2018, 43.
  24. Menon, S.H., Lai, L.L., Chan, W.K.,Mustapha, N.R.N., Vijayananthan,A., & Mahadeva, S. (2018). Comparison of HepaFat-Scan and controlled attenuation parameter for the estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease using histology as the reference standard. Journal of Hepatology, 68 (1), S569 S570. https://doi.org/10.1016/S0168-8278(18)31396-5.
  25. Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki K, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VWS. Non-alcoholic fatty liver disease demographic features, risk factors and treatment practices across the Asia Pacific region the GO ASIA initiative. J Hepatol 2017; 66(1): S595.
  26. Lai LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, Goh KL, Mahadeva S. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein as a serum biomarker for disease severity in nonalcoholic fatty liver disease. J Hepatol; 66(1): S676. .
  27. Pitisuttithum, P., Chan, W. K., Imajo, K., Nakajima, A., Seki, Y., Kasama, K., Kakizaki, S., Fan, J. G., Song, M. J., Yoon, S. K., Dan, Y. Y., Lesmana, L. A., Ho, K. Y., Goh, K. L., Wong , V., Treeprasertsuk, S. (2017).The high prevalence and predictors of advance fibrosis in elderly patients with liver biopsy confirmed non-alcoholic fatty liver disease (NAFLD)-The GOASIA STUDY, American association for the study of liver disease 2017, pg S-1199.
  28. Sivesh K Kamarajah, Wah Kheong Chan, Nik Raihan Mustapha, Sanjiv Mahadeva, Outcomes of Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD) in South East Asian Patients: A Single Tertiary Center Experience, Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 36
  29. Stanley Khoo, Wah Kheong Chan, KL Goh, A Substantial Proportion of Patients with Chronic Hepatitis B have Significant Fibrosis and Concomitant Fatty Liver: Results from a Cross-Sectional Study Using FibroScan at Major Tertiary Hospital in Malaysia, Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 41
  30. Sumitra Ropini Karuthani, Wah Kheong Chan, Peng Soon Koh, Karuthan Chinna, Comparing the BCLC and HKLC staging systems in the management of hepatocellular carcinoma in a tertiary center in Malaysia, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 154-194.
  31. Wah Kheong Chan , Sombat Treeprasertsuk , Kento Imajo , Atsushi Nakajima , Yosuke Seki , Kazunori Kasama , Satoru Kakizaki , Jian Gao Fan , Myeong Jun Song , Seung Kew Yoon , Yock Young Dan , Laurentius Lesmana , Khek Yu Ho , Khean Lee Goh , Vincent Wai Sun Wong (2017) Non-alcoholic fatty liver disease- demographic features, risk factors and treatment practices across the Asia Pacific region-the GOASIA initiative, American association for the study of liver disease 2017.
  32. Wah Kheong Chan, Management of NAFLD case discussion. Paper presented at the MEMS Annual Congress 2017 (MAC 8),
  33. Wah Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Vincent Wai-Sun Wong, Jenny Yeuk-Ki Cheng, Grace Lai-Hung Wong, Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan )?, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 154-194.
  34. Wah Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Vincent Wai-Sun Wong, Jenny Yeuk-Ki Cheng, Grace Lai-Hung Wong, Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan )?Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 43
  35. Yeong Yeh Lee, Jianyi Calvin Koh, Mung Seong Wong, Rona Marie Lawenko, Sombat Treeprasertsuk, Siok Chiang Fan, Wai Mun Loo, Wah Keong Chan, Vincent WS Wong, Ajay Duseja, Sutep Gonlachanvit, Murdani Abdullah, Yeon-Young Chuah, Jose Sollano, Myung-Gyu Choi, Kentaro Sugano, Khean Lee Goh, Khek Yu Ho, Dan Yock Young, GO ASIA WORKING GROUP, Perception and bariatric practices of obesity-related gastrointestinal (GI) disease among Asian GI practitioners: GOASIA working group initiative, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 26-28.
  36. Chan, W.K., Nik Mustapha, N.R., & Mahadeva, S. (2016). Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 356. 10.1111/jgh.13540
  37. Chan, W.K., Yeoh, K.Y.,LIM, C.Y., LAIL, S.M., Lee, J.L., Leow, A.H.R.,...& Goh, K.H. (2016). Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 356. 10.1111/jgh.13540
  38. E.C.L. Tan, S.M.L. Tai, Wah-kheong Chan, Sanjiv Mahadeva. A Study of Non-Alcoholic Fatty Liver Disease Using Trasient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-Aged Malaysian Cohort. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 62
  39. Khoo,S.,Chan, W.K., Mahadeva, S. & Nik Mustapha, N.R.(2016). Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Ballooning and Adult NAFLD Patients: Non-invansive Biomarkers in Diagnosis of Non-Alcoholic Steatohapetitis (NASH) in Adult Patients. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 389. 10.1111/jgh.13540
  40. Li, E.T.C., Tai, S.M.L., Chan, W.K., Abd Rahman, R. & Mahadeva, S. (2016). A Study of Non-Alcoholic Fatty Liver Disease Using Transient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-aged Malaysian Population. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 385. 10.1111/jgh.13540
  41. Ruveena Rajaram & Wah-Kheong Chan. Is Silymarin Useful for the Treatment of Non- Alcoholic Fatty Liver Disease?: A Meta Analysis. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 76
  42. Stanley Khoo, Wah Kheong Chan, Sanjiv Mahadeva, Nik Raihan Nik Mustapha. Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Balloning in Adult NAFLD Patients: Non Invalsive Biomarkers in Diagnosis of Non Alcoholic Steatohapetitis (NASH) In Adult patients.Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 68
  43. Wah Kheong Chan. (2016, Nov). An Asian Multicentre Study On Biopsy-Proven NAFLD Patients-Part of The GO ASIA Initiative.Paper presented at the Asian Pacific Digestive Week APDW 2016, Kobe, Japan.
  44. Wah Kheong Chan. (2016, Nov). New Therapeutic Options for NAFLD.Paper presented at the Asian Pacific Digestive Week APDW 2016, Kobe, Japan.
  45. Wah-Kheong Chan, Kee-Ying Yeoh, Chia-Ying Lim, Su-Meng Lai, Jac-Lyn Lee, Alex Hwong-Ruey Leow, Khean- Lee Goh. A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 56
  46. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A randomized, double-blind, placebo- controlled trial of silymarin for the treatment of non-alcoholic steatohepatitis. Hepatol Int 2016; 10 (Suppl 1.): S455.
  47. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 80
  48. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis. J Hepatol 2016; 64 : S225-226.
  49. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A novel 2 step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatol Int 2015; 9 (Suppl 1): S372-3.
  50. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol 2015; 30 (Suppl. 4): 324.
  51. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease? Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, page
  52. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease? J Gastroentrol Hepatol 2015; 30 (Suppl. 4): 327.
  53. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind placebo-controlled trial. EMJ Hepatol 2015; 3(2): 84-6.
  54. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. J Hepatol 2015; 62(2): S269.
  55. Wah-Kheong Chan, Nik Raihan Nik Mustapha. Sanjiv Mahadeva. Silymarin for the treatment of non- alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, page 34
  56. Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Hepatol Int 2015; 9 (Suppl 1): S362.
  57. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2014; 29 (Suppl. 3): 183-4
  58. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 49.
  59. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 48
  60. Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. Hepatol Int. 2014; 8(Suppl. 1): 353-4.
  61. Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. J Gastroenterol Hepatol. 2014; 29 (Suppl. 3): 182-3.
  62. Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 50.
  63. Ahmad Najib Azmi, Wah-Kheong Chan, Sanjiv Mahadeva, Khean-Lee Goh. Split versus whole-dose PEG-ELS for bowel preparation in outpatient colonoscopy. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 29.
  64. Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography-diagnosed NAFLD is not associated with IHD among long-standing poorly- controlled diabetics. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 407.
  65. Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography-diagnosed non-alcoholic fatty liver disease (NAFLD) is not associated with prevalent ischemic heart disease (IHD) among long- standing poorly controlled diabetics. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 55.
  66. Wah-Kheong Chan, Alexander Tong-Boon Tan, Vethakkan Shireene Ratna, Pei-Chien Tah, Vijayananthan Anushya, Khean-Lee Goh. Low physical activity and high percentage calorie intake from fat, high cholesterol food and high saturated fatty acid food is associated with NAFLD in centrally obese diabetics. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 57.
  67. Wah-Kheong Chan, Ida Normiha Hilmi, Phaik-Leng Cheah, Khean-Lee Goh. Progression of non-alcoholic fatty liver disease (NAFLD) a prospective clinicopathological follow-up study. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 42.
  68. Wah-Kheong Chan, Najib Azmi, Sanjiv Mahadeva, Khean-Lee Goh. Reduced-volume PEG-ELS plus bisacodyl split- dose is better than same morning whole-dose for morning outpatient colonoscopy: result of an investigator- and endoscopist-blinded, randomized study. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 72.
  69. Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sithaneshwar, Khean-Lee Goh. Non-alcoholic fatty liver disease in young adults worrying ethnic differences in a multi-racial Asian population in Malaysia. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 56.
  70. Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sthaneshwar, Khean-Lee Goh. Prevalence of NAFLD and associated factors among multi- racial Malaysian population. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 407.
  71. W K Chan, A C Roslani, C W Law, K L Goh, S Mahadeva. Endoluminal clipping versus surgery in the management of iatrogenic colonic perforation: a direct cost analysis. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2012, page 117.
  72. W K Chan, A T B Tan, S R Vethakkan, P C Tah, A Vijayananthan, K L Goh. Prevalence of NAFLD among diabetic patients in the outpatient clinic of a Malaysian hospital and associated factors. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2012, page 55.
  73. W K Chan, A T B Tan, S R Vethakkan, P C Tah, A Vijayananthan, K L Goh. The role of diet and physical activity in non-alcoholic fatty liver disease (NAFLD) in diabetic patients. Proceeding The 3rd Asian-Pacific Topic Conference, page 175.
  74. W K Chan, P L Cheah, I N Hilmi, K L Goh. Clinical and histological follow-up of a cohort of patients with NAFLD. J Gastroenterol Hepatol 2012; 27 (Suppl. 5): 242.
  75. A N Azmi, W K Chan, S H Ho, K L Goh. Patient satisfaction of outpatient gastroscopy in University of Malaya Medical Centre endoscopy unit. J Gastroenterol Hepatol 2011; 26 (Suppl. 5): 58.
  76. N A Azmi, W K Chan, S H Ho, K L Goh. Patient satisfaction of outpatient gastroscopy in University Malaya Medical Centre endoscopy unit. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011, page 46.
  77. W K Chan, A C Roslani, K L Goh, S Mahadeva. Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011, page 68.
  78. W K Chan, A C Roslani, K L Goh, S Mahadeva. Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital. J Gastroenterol Hepatol 2011; 26 (Suppl. 5): 117.
  79. W K Chan, A Saravanan, J Manikam, K L Goh, S Mahadeva. Risk factors for poor bowel preparation and its impact on technical performance and patient comfort in an Asian population. J Gastroenterol Hepatol 2010; 25(Suppl. 2): A61.
  80. W K Chan, K L Goh. Patient satisfaction with various aspects of an outpatient colonoscopy service. J Gastroenterol Hepatol 2010; 25 (Suppl. 2): A60.
Other Publications
  1. Chan, W. K., & Wong, V. W. S. (2022). Meaning of non overlapping patients between the MAFLD and NAFLD definitions. [Editorial]. Liver International, 42(2), 271-273. - Editorial Material
  2. Chan, W.K. and Wong, V.W.-S. (2021). Editorial: metagenome-assembled genomes in non-alcoholic fatty liver disease. [Editorial]. Aliment Pharmacol Ther, 53: 755-756. https://doi.org/10.1111/apt.16280. - Editorial Material
  3. Goh, G.B.-B., Chan, W.K. and Wong, V.W.-S. (2021), Breastfeeding to Prevent NAFLD. [Editorial]. Hepatology. https://doi.org/10.1002/hep.32095. - Editorial Material
  4. Pan, Z., Chan, W. K., & Eslam, M. (2021). The role of B cells in metabolic (dysfunction)-associated fatty liver disease. [Editorial]. Hepatobiliary Surgery and Nutrition, 10(6), 875. - Editorial Material
  5. Tan, S. S., Lee, Y. Y., Ali, R. A. R., Mustapha, F., & Chan, W. K. (2021). Endorsing the redefinition of fatty liver disease. [Editorial]. The Lancet Gastroenterology & Hepatology, 6(3), 163. https://doi.org/10.1016/S2468-1253(21)00002-9. - Editorial Material
  6. Younossi, Z. M., Ong, J. P., Takahashi, H., Yilmaz, Y., Eguchi, Y., El Kassas, M., ... & Council, G. N. S. (2021). A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. - Meeting Abstract
  7. Younossi, Z. M., Yilmaz, Y., Yu, M. L., Wong, V., Fernandez, M. C., Isakov, V., ... & Stepanova, M. (2021). 342 Clinical presentation of lean non-alcoholic fatty liver disease (NAFLD) across the world: data from the Global NASH Registry. Gastroenterology, 160(6), S-771. - Meeting Abstract
  8. Yu, M. L., El Kassas, M., Yilmaz, Y., Fernandez, M. C., Buti, M., Papatheodoridis, G., ... & Younossi, Z. M. (2021). Sa313 Clinical presentation and patient-reported outcomes in patients with chronic viral hepatitis: data from the Global Liver Registry . Gastroenterology, 160(6), S-821. - Meeting Abstract

RESEARCH PROJECT


National
  1. 2022 - 2028, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    THE EFFECT OF SEMAGLUTIDE IN SUBJECTS WITH NON-CIRRHOTIC NON-ALCOHOLIC STEATOHEPATITIS ( Co-Researcher)
  2. 2022 - 2025, DEPARTMENT OF MEDICINE (DOM)
    EUS guided portal-systemic pressure gradient measurement to predict treatment response and outcomes of varices to endoscopic variceal ligation in patients with chronic hepatitis. ( Co-Researcher)
  3. 2021 - 2024, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    EFFICACY AND SAFETY INVESTIGATION OF NNC0194-0499 CO-ADMINISTERED WITH SEMAGLUTIDE IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A DOSE-RANGING, PLACEBO-CONTROLLED TRIAL ( Principal Investigator(PI))
  4. 2015 - 2020, NONE
    Prognostication of non-alcoholic fatty liver disease using controlled attenuation parameter and liver stiffness measurement by Fibroscan ( Consultant)
  5. 2016 - 2018, Private Funding
    Open label phase II/III, multicenter, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir in HCV (+/- HIV) chronically infected adults with no or compensated cirrhosis in Thailand and Malaysia ( Consultant)
  6. 2016 - 2016, NONE
    Macroscopic on-site quality evaluation of biopsy specimens to improve the diagnostic accuracy during EUS-guided FNA using a 19-gauge needle for solid lesions: a multicenter prospective randomized controlled study ( Consultant)
  7. 2016 - 2016, NONE
    Gut and Obesity in Asia: Spectrum of non-alcoholic fatty liver disease in Asia: a retrospective cohort study ( Consultant)
  8. 2013 - 2015, NONE
    Integrating non-invasive methods for assessment of patients with non-alcoholic fatty liver disease ( Principal Investigator(PI))
  9. 2014 - 2015, NONE
    A study on the vertical transmission of hepatitis B virus infection in Malaysia ( Principal Investigator(PI))
  10. 2015 - 2015, NONE
    Controlled attenuation parameter using Fibroscan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease ( Principal Investigator(PI))
  11. 2015 - 2015, Private Funding
    EndoBarrier SANS in Over-weight or Obese Type 2 Diabetic Subjects ( Principal Investigator(PI))
  12. 2012 - 2014, Madaus GmbH
    A Randomized, Double-Blind, Placebo-Controlled,Phase II, Single-Centre Study to Evaluate theSafety and Efficacy of Silymarin 700 mg TID forthe Treatment of Non-Alcoholic Fatty Liver Disease ( Consultant)
  13. 2013 - 2014, NONE
    Randomized study on split-dose versus whole-dose polyethylene glycol electrolyte lavage solution plus bisacodyl for bowel preparation for adult patientsundergoing outpatient colonoscopy ( Consultant)
  14. 2013 - 2014, Geran Penyelidikan Universiti Malaya (UMRG)
    Validation of the Enhanced Liver Fibrosis panel for estimation of fibrosis in patients with non-alcoholic fatty liver disease ( Consultant)
  15. 2010 - 2013, MSGH Research Grant
    Clinical and Histological Follow-Up of Cohort ofPatient with Non-Alcoholic Fatty Liver Disease ( Principal Investigator(PI))
  16. 2012 - 2013, NONE
    Prevalence of non-alcoholic fatty liver disease (NAFLD) and associated factros in a young, multi-racial Malaysian population. ( Principal Investigator(PI))
  17. 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG)
    Prevalence of Fatty Liver among Outpatient Diabetic Patients in an Asian Tertiary Care Hospital ( Principal Investigator(PI))
  18. 2010 - 2012, Celsion
    A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of Thermodox (Thermally Sensitive Liposomal Doxorubicin) in Combination with Radiofrequency Ablation (RFA) Compared to RFA Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma ( Consultant)
  19. 2010 - 2011, MSGH Research Grant
    Evaluation of Patient Satisfaction of an Outpatient Gastroscopy Service in an Asian Tertiary Care Hospital ( Consultant)
  20. 2011 - 2011, NONE
    Iatrogenic Colonic Perforation: A 6-year Single Centre Experience of Endoscopic and Surgical Management ( Principal Investigator(PI))
  21. 2010 - 2010, NONE
    A validation study of the Leeds Dyspepsia Questionnaire in a multi-ethnic Asian population. ( Consultant)
  22. 2010 - 2010, NONE
    Evaluation of Patient Satisfaction of an Outpatient Colonoscopy Service in an Asian Tertiary Care Hospital. ( Principal Investigator(PI))
International
  1. 2022 - 2025, ASTRAZENECA SDN. BHD.
    A Phase IIb/III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Cotadutide in Participants with Non-cirrhotic Non-alcoholic steatohepatitis with Fibrosis (PROXYMO-ADVANCE) ( Principal Investigator(PI))
  2. 2023 - 2025, Astrazeneca Sdn. Bhd
    A Randomised, Double-blind, Placebo-controlled, Multi-centre Phase 2b Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 in Participants with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) with Fibrosis Who Are Carriers of the PNPLA3 rs738409 148M Risk Allele ( Principal Investigator(PI))
  3. 2021 - 2023, Boehringer Ingelheim Singapore Pte. Ltd.
    Multicenter, double-blind, parallel-group, randomised, 48 weeks, dose-ranging, placebo-controlled phase II trial to evaluate efficacy, safety and tolerability of multiple subcutaneous (s.c.) doses of BI 456906 in patients with non-alcoholic steatohepatitis (NASH) and fibrosis ( Principal Investigator(PI))
  4. 2017 - 2023, Private Funding
    A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis ( Principal Investigator(PI))
  5. 2017 - 2019, NONE
    Validation of 2-step approach in non-invasive assessment of NAFLD ( Principal Investigator(PI))
  6. 2016 - 2017, Private Funding
    Validation of a MRI-based classification of hepatic fibrosis ( Principal Investigator(PI))
  7. 2016 - 2017, Private Funding
    Mac-2 binding protein glycosylation isomer for diagnosis of NASH and fibrosis in patients with NAFLD ( Principal Investigator(PI))
  8. 2014 - 2015, Pharmaceutical
    CELSION OPTIMA ( Consultant)
  9. 2013 - 2014, The Swami Institute for International Medical Education Grant
    Molecular and metabolic distinction of non-alcoholic fatty liver disease and type 2 diabetes mellitus ( Consultant)

CONSULTANCY PROJECT


  • Consultant Gastroenterologist, University of Malaya Medical Centre
    01 Dec 2013 - 01 Dec 2020 (National)
  • Consultant Gastroenterologist, University of Malaya Specialist Centre
    01 Dec 2014 - 01 Dec 2020 (National)
  • Reaching a Consensus On Optimising The Use of Nexavar in Hcc., Bayer HealthCare Pharmaceuticals
    01 Oct 2014 - 01 Oct 2014 (National)

PAPER PRESENTED


PLENARY SPEAKER
  1. Policy Review for MAFLD: Policies and Strategy in MAFLD: South-East Asia View, APASL Single Topic Conference on MAFLD, Taiwan Association for the Study of the Liver (International) (28 Jun 2024 - 30 Jun 2024)
  2. Prognostic value of LSM measured by FibroScan and Prognostic value of blood markers and focus on FibroMeter, Pronostic value of FibroScan and FibroMeter in Chronic liver diseases, Echosens Webinar (International) (07 Dec 2016 - 07 Dec 2016)
INVITED SPEAKER
  1. MAFLD: Clinical Features and Implications, The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2024), Asian Pacific Association for the Study of the Liver (International) (27 Mar 2024 - 31 Mar 2024)
  2. Screening for advanced liver fibrosis as a strategy for early diagnosis of hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease, The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL2024), Asian Pacific Association for the Study of the Liver (APASL) (International) (27 Mar 2024 - 31 Mar 2024)
  3. Assessment of CAD risk in MAFLD, Asian Pacific Digestive Week 2023, Asian Pacific Digestive Week Federation (International) (07 Dec 2023 - 09 Dec 2023)
  4. Improvement in Nonalcoholic fatty liver disease: The Holistic Approach, Asian Pacific Digestive Week 2023-PG Course, Asian Pacific Digestive Week Federation (International) (06 Dec 2023 - 06 Dec 2023)
  5. Update on MASLD and Role of Transient Elastography, 7th Sabah International Endoscopy Workshop 2023, Gastroenterology Unit, QEH (International) (23 Nov 2023 - 25 Nov 2023)
  6. How to Produce High Quality Research, 7th Sabah International Endoscopy Workshop 2023, Gastroenterology Unit, HQE (International) (23 Nov 2023 - 25 Nov 2023)
  7. Non-invasive Test for Metabolic Dysfunction Associated Fatty Liver Disease: An Important Piece of the Puzzle, Taiwan Digestive Disease Week 2023, The Gastroenterological Society of Taiwan (GEST) (International) (23 Sep 2023 - 24 Sep 2023)
  8. Biomarkers of NASH and Advanced Liver Fibrosis, Taiwan Digestive Week 2023, The Gastroenterological Society of Taiwan (GEST) (International) (23 Sep 2023 - 24 Sep 2023)
  9. NAFLD: The Malaysian Perspective, Malaysian Endocrine and Metabolic Society Evening Webinar, Malaysian Endocrine and Metabolic Society (National) (05 Dec 2022 - 05 Dec 2022)
  10. Fatty liver - relook on how to manage, College of Physicians Malaysia Malaysian Advanced Acute Internal Medicine and Ultrasound Society Annual Scientific Congress, College of Physicians Malaysia Malaysian Advanced Acute Internal Medicine and Ultrasound Society  (National) (01 Dec 2022 - 03 Dec 2022)
  11. Recent issues in MAFLD, 2022 International Congress of Diabetes and Metabolism (ICDM 2022), International Congress of Diabetes and Metabolism Secretariat (International) (06 Oct 2022 - 08 Oct 2022)
  12. Colon cancer, am I at risk? What can I do about it?, Malaysia Network of Caring Communities Zoom Online Talk , Malaysia Network of Caring Communities (National) (01 Oct 2022 - 01 Oct 2022)
  13. I have hepatitis B. What does it mean and what should I do?, Malaysia Network of Caring Communities Zoom Online Talk, Malaysia Network of Caring Communities (National) (10 Sep 2022 - 10 Sep 2022)
  14. Meaning of non-overlapping patients between the MAFLD and NAFLD definitions, 7th Shanghai International Conference on Digestive Diseases, Shanghai International Conference on Digestive Diseases Secretariat (International) (02 Sep 2022 - 04 Sep 2022)
  15. FXR agonists and FGF analogues, International Digestive Disease Forum 2022, International Digestive Disease Forum Secretariat (International) (02 Sep 2022 - 04 Sep 2022)
  16. The MSGH Consensus Statements on MAFLD Introduction, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2022, The Malaysian Society of Gastroenterology and Hepatology (National) (19 Aug 2022 - 21 Aug 2022)
  17. GO ASIA Initiative: Finding the Right Patient for ESSENCE, Novo Nordisk Asia Pacific Regional Forum on NASH, Novo Nordisk (International) (29 Jul 2022 - 29 Jul 2022)
  18. I have fatty liver. What does it mean and what should I do?, MNCC Zoom Online Talk, Malaysia Network of Caring Communities (National) (16 Jul 2022 - 16 Jul 2022)
  19. Managing Fatty Liver in Primary Care, 12th MEMS Annual Congress 2022 (MAC12), Malaysian Endocrine and Metabolic Society (International) (15 Jul 2022 - 17 Jul 2022)
  20. Fatty liver: what is it and what can I do about it?, Body and Mind Workshop, Tzu Chi International Medical Association (International) (18 Jun 2022 - 18 Jun 2022)
  21. MAFLD: from epidemiological features to holistic management approach, Metabolic dysfunction-Associated Fatty Liver Disease (MAFLD): The need for a holistic view, Viatris Healthcare (International) (10 Jun 2022 - 10 Jun 2022)
  22. Transient elastography in MAFLD: beyond diagnosis of liver fibrosis, APASL STC Beijing 2022 Liver Fibrosis in the Era of Translational Medicine, Asian Pacific Association for the Study of the Liver (International) (03 Jun 2022 - 05 Jun 2022)
  23. Obesity and fatty liver, Nursing Webinar Session 10/2022 Gastroenterology Enhancing Basic Skills and Developing Expertise, Department of Nursing (University) (20 Apr 2022 - 20 Apr 2022)
  24. Application of transient elastography, Challenges in Liver Cirrhosis Management : Diagnosis and Treatment, Indonesian Association for the Study of the Liver (International) (17 Apr 2022 - 17 Apr 2022)
  25. Current challenge and opportunity in emerging treatment for NAFLD, 31st Conference of the Asian Pacific Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver (International) (30 Mar 2022 - 03 Apr 2022)
  26. Metabolic hormone analogues, 31st Conference of the Asian Pacific Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver (International) (30 Mar 2022 - 03 Apr 2022)
  27. Overview of NAFLD and MAFLD - is this the same disease entity?, College of Physicians Malaysia Weekly Webinar, College of Physicians Malaysia (National) (06 Jan 2022 - 06 Jan 2022)
  28. Bile acids in the pathogenesis and treatment of NASH, 33rd Annual Scientific Meeting (Webinar) and International Symposium on Hepatology, The Hong Kong Association for the Study of Liver Diseases (International) (29 Nov 2020 - 29 Nov 2020)
  29. Pharmacological Treatments for NAFLD, International Digestive Disease Forum HYBRID 2020, Institute of Digestive Disease (IDD) of The Chinese University of Hong Kong (CUHK) (International) (22 Nov 2020 - 23 Nov 2020)
  30. DAA Elimination in Special Population, International Digestive Disease Forum HYBRID 2020, Institute of Digestive Disease (IDD) of The Chinese University of Hong Kong (International) (22 Nov 2020 - 23 Nov 2020)
  31. Who needs pharmacological treatment?, 20th PGI-AIIMS Current Perspectives in Liver Disease-CPLD 2020 Virtual Conference, Department of Hepatology, PGIMER,Chandigarh and Department of Gastroenterology, AIIMS, New Delhi (International) (10 Oct 2020 - 11 Oct 2020)
  32. Analysis of continuous data, Asian Pacific Digestive Week 2019, Asian Pacific Digestive Week 2019 Kolkata (International) (11 Dec 2019 - 15 Dec 2019)
  33. Interventional studies, including randomized controlled trials , Asian Pacific Digestive Week 2019, Asian Pacific Digestive Week 2019 Kolkata (International) (11 Dec 2019 - 15 Dec 2019)
  34. Epidemiology of NASH in Asia Pacific, Asian Pacific Digestive Week 2019 (NASH Symposium), Asian Pacific Digestive Week 2019 Kolkata (International) (11 Dec 2019 - 15 Dec 2019)
  35. Emerging Therapy for NAFLD, Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019, Malaysian Society of Gastroenterology & Hepatology (International) (16 Aug 2019 - 18 Aug 2019)
  36. Silymarin in NAFLD, Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019, Malaysian Society of Gastroenterology & Hepatology (International) (16 Aug 2019 - 18 Aug 2019)
  37. Non-invasive diagnosis of liver fibrosis: serological, mechanical or both?, Singapore Hepatology Conference, Singapore Hepatology Conference Pte Ltd (International) (07 Jun 2019 - 08 Jun 2019)
  38. Optimising Comprehensive Management of NASH, Singapore Hepatology Conference, Singapore Hepatology Conference Pte Ltd (International) (07 Jun 2019 - 08 Jun 2019)
  39. Impact of steatosis on viral hepatitis, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, Asia Pacific Association for the Study of Liver (International) (20 Feb 2019 - 24 Feb 2019)
  40. Moderate alcohol intake in NAFLD: good or bad?, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, Asia Pacific Association for the Study of Liver (International) (20 Feb 2019 - 24 Feb 2019)
  41. Enhancing Patient Care with Fibroscan, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology (GUT 2018), Malaysian Society of Gastroenterology and Hepatology (International) (13 Jul 2018 - 15 Jul 2018)
  42. Roadblocks to Research - Local Perspectives , Annual Scientific Meeting for the Malaysian Society of Gastroenterology and Hepatology (GUT 2018), Malaysian Society of Gastroenterology and Hepatology  (International) (13 Jul 2018 - 15 Jul 2018)
  43. Pathophysiology and risk factors for NAFLD, Singapore Hepatology Conference 2018, Singapore Hepatitis Conference Pte Ltd (International) (08 Jun 2018 - 09 Jun 2018)
  44. NAFLD- Current Management Strategies, MSGH Update in Gastroenterology and Hepatology, Malaysian Society of Gastroenterology and Hepatology (National) (03 Mar 2018 - 03 Mar 2018)
  45. Latest Update from University Malaya Leading Research Team in NAFLD, What are the current treatment options for NAFLD , Milan Pharmaceuticals, Inc (National) (11 Nov 2017 - 11 Nov 2017)
  46. What and how common is NAFLD, Latest Update from University Malaya Leading Research Team in NAFLD, Milan Pharmaceuticals, Inc (National) (11 Nov 2017 - 11 Nov 2017)
  47. A Practical Approach in the Assessment of NAFLD, Annual Scientific Meeting 2017 (Mastering the Art of Challenging Diagnosis, Minimizing Misses), Annual Scientific Meeting of College of Physicians, AMM (National) (09 Nov 2017 - 12 Nov 2017)
  48. An Update on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis , MIMS Doctor, Special reports interview., MIMS Gastroenterology (International) (01 Oct 2017 - 01 Oct 2017)
  49. Racial and ethnic differences in NAFLD, Asia Pacific Digestive Week Federation (APDW) 2017 Hong Kong, Asian Pacific Digestive Week (APDW) 2017 (International) (23 Sep 2017 - 26 Sep 2017)
  50. Epidemiology in Asia-Pacific, Asia Pacific Digestive Week Federation (APDW) 2017 Hong Kong, Asian Pacific Digestive Week (APDW) 2017 (International) (23 Sep 2017 - 26 Sep 2017)
  51. Racial and ethnic differences in NAFLD, Annual Scientific Meeting of the Indian National Association for the Study of the Liver 2017 (25th Silver Jubilee), Indian National Association for the Study of the Liver (INASL) (International) (03 Aug 2017 - 06 Aug 2017)
  52. Identifying Patients At Risk for NAFLD, Singapore Hepatology Conference 2017, Singapore Hepatitis Conference Pte Ltd (International) (02 Jun 2017 - 03 Jun 2017)
  53. Management of NAFLD case discussion, MEMS Annual Congress 2017 (MAC 8), Malaysian Endocrine and Metabolic Society (National) (19 May 2017 - 21 May 2017)
  54. New Pharmacological Treatment for NASH , MSGH Update in Gastroenterology and Hepatology, Malaysian Society of Gastroenterology and Hepatology (National) (04 Mar 2017 - 04 Mar 2017)
  55. New Pharmacological Treatment for NASH , MSGH Update In Gastroenterology and Hepatology , Malaysian Society of Gastroenterology and Hepatology (National) (04 Mar 2017 - 04 Mar 2017)
  56. New Solution for NASH Management, 56th Gat Annual Meeting 2016: The Gastroenterological Association Of Thailand, The Gastroenterological Association Of Thailand (International) (28 Nov 2016 - 30 Nov 2016)
  57. Non-Alcoholic Fatty Liver Disease (NAFLD): Are We Doing Enough?, 15TH CONTINUING PROFESSIONAL DEVELOPMENT (CPD) SERIES : DIABETES ASIA 2016 CONFERENCE, NADI : NATIONAL DIABETES INSTITUTE (National) (06 Oct 2016 - 09 Oct 2016)
  58. The AASLD Guideline on Hepatitis C Treatment, Hepatitis C Treatment Referral Advisory Board Meeting Agenda , LF ASIA  (National) (13 Mar 2016 - 13 Mar 2016)
  59. General Concepts and Basic Technique of Esophageal Stenting, GI Stenting Training Course, The Digestive Endoscopy Society of Taiwan (International) (09 Jan 2016 - 09 Jan 2016)
  60. EUS-FNA: Technique and Improving Yield, ERCP and EUS Proctorship Workshop, Sanpya General Hospital (International) (12 Oct 2015 - 13 Oct 2015)
  61. Live Case Demonstration, ERCP and EUS Proctorship Workshop , Sanpya General Hospital (International) (12 Oct 2015 - 13 Oct 2015)
  62. Pathogenesis of NAFLD, Hepato Metabolic GP Workshop, MEDA Rottapharm Madaus (National) (05 Sep 2015 - 06 Sep 2015)
  63. NAFLD-Pathogenesis , 11th Liver Update 2015 International Conference , Malaysian Liver Foundation  (International) (30 Jul 2015 - 02 Aug 2015)
  64. Diagnosis and management of non-alcoholic fatty liver disease, EXPERT Summit 2015, Sanofi (National) (16 May 2015 - 16 May 2015)
  65. Fatty Liver Research Discussion , Fatty Liver Symposium, Malaysian Liver Foundation  (National) (02 Nov 2014)
  66. Pathophysiology , Fatty Liver Symposium , Malaysian Liver Malaysian (National) (02 Nov 2014)
  67. NAFLD: Cause or Effect?, Diabetes Asia 2014 Conference, NADI (National Diabetes Institute) (National) (16 Oct 2014 - 19 Oct 2014)
  68. Anti-Viral therapy for secondary and tertiary prevention of HCC, 2014 THOMAS The Hepatic Oncology Multi-Disciplinary Approach Symposium, 2014 THOMAS The Hepatic Oncology Multi-Disciplinary Approach Symposium (International) (11 Oct 2014 - 12 Oct 2014)
  69. How To Prevent Post-Treatment (RFA, resection, TACE) liver decompensation, 2014 THOMAS The Hepatic Oncology Multi-Disciplinary Approach Symposium, 2014 THOMAS The Hepatic Oncology Multi-Disciplinary Approach Symposium (International) (11 Oct 2014 - 12 Oct 2014)
  70. Predicting disease progression and mortality in NAFLD , GUT 2014 and ECCO Educational Workshop, Malaysian Society of Gastroenterology and Hepatology  (National) (22 Aug 2014 - 24 Aug 2014)
  71. Management of GERD; symptoms vs. patient s needs, A to Z Primary Care Updates, AstraZeneca, Malaysian Medical Association (Sarawak Branch) (National) (06 Jul 2014)
  72. Local practice in Malaysia on bowel preparation and what's new, Right from the Start: Clean, clear colon for early detection and accurate medical decision, EP Plus Gastro Care (National) (23 Jun 2014)
  73. An Overview and Practical Management of NAFLD, 7th Postgraduate Course In Hepatology "The Bread & Butter of Liver Disease and Their Management", Hepatology Department, Selayang Hospital. Ministry of Health Malaysia (Others) (26 Apr 2014)
  74. Large Polypectomy/EMR, Endoscopy 2014 - Annual Workshop in Interventional GI Endoscopy, University of Malaya (National) (28 Mar 2014)
  75. Update on NAFLD - what is the latest?, MSGH Update in Gastroenterology and Hepatology, Malaysian Society of Gastroenterology and Hepatology (National) (15 Feb 2014)
  76. Diagnosis and Management of GERD, Pharmacy Summit Meeting, Malaysian Pharmaceutical Association and Astra Zeneca (National) (06 Oct 2013)
  77. Technical aspects of colonic polyp removal, Basic Endoscopy Course 2013, University of Malaya (National) (21 Jun 2013)
  78. Overview of endoscopic management of variceal bleeding, Basic Endoscopy Course 2013, University of Malaya (National) (21 Jun 2013)
  79. Measuring Fibrosis and Cirrhosis in Chronic Hepatitis C: Liver Biopsy and Fibroscan, Preceptorship on Hepatitis C Treatment - Cambodia, Roche Cambodia (International) (18 Feb 2013 - 18 Feb 2013)
  80. Management of Chronic Hepatitis C in Patient with Chronic Renal Failure, Preceptorship on Hepatitis C Treatment - Cambodia, ROCHE Cambodia (International) (17 Feb 2013 - 17 Feb 2013)
  81. Improving Outcomes of Patients with Hepatitis C: A Local Perspective, Preceptorship for Hepatitis C Treatment, ROCHE (National) (07 Oct 2012 - 07 Oct 2012)
  82. Measuring Fibrosis and Cirrhosis in Chronic Hepatitis C: Liver Biopsy and Fibroscan , Preceptorship on Hepatitis C Treatment, ROCHE Vietnam and University of Malaya Medical Centre (International) (13 Aug 2012 - 13 Aug 2012)
  83. Management of Chronic Hepatitis C in Patient with Chronic Renal Failure, Preceptorship for Hepatitis C Treatment, ROCHE Vietnam  (International) (12 Aug 2012 - 12 Aug 2012)
  84. Technical Aspect of Colonic Polyp Removal, 1st ERBE-UMMC Training Workshop in Therapeutic Endoscopy,, ERBE and University of Malaya Medical Centre (International) (01 Jul 2011 - 01 Jul 2011)
  85. Non-alcoholic fatty liver disease: what do we know so far?, 10th Pharmacy Nite Seminar: What Pharmacists Know, Malaysian Pharmaceutical Society (National) (01 Aug 2010 - 01 Aug 2010)
ORAL PRESENTER
  1. LONG-TERM CLINICAL OUTCOMES OF ADULTS WITH BIOPSY-PROVEN METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE: A SINGLE-CENTRE PROSPECTIVE COHORT STUDY, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2022, The Malaysian Society of Gastroenterology and Hepatology (National) (19 Aug 2022 - 21 Aug 2022)
  2. HIGH PROPORTION OF HEPATIC STEATOSIS AND METABOLIC RISK FACTORS AMONG CHRONIC HEPATITIS B PATIENTS: THE MULTI-CENTRE CAP-ASIA STUDY, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2022, The Malaysian Society of Gastroenterology and Hepatology (National) (19 Aug 2022 - 21 Aug 2022)
  3. High proportion of hepatic steatosis and metabolic risk factors among chronic hepatitis B patients: the multi-centre, prospective CAP-Asia study, The 31st Conference of the Asian Pacific Association for the Study of the Liver (APASL 2022), Organizing Committee of APASL 2022 (International) (30 Mar 2022 - 03 Apr 2022)
  4. Physical activities among patients with nonalcoholic fatty liver disease in Hong Kong, Shanghai, Singapore and Malaysia, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, Asia Pacific Association for the Study of Liver (International) (20 Feb 2019 - 24 Feb 2019)
  5. Technique of linear radial EUS, Endoscopy 2018 " Therapeutic Endoscopy: Building on Basics", Malaysian Society of Gastroenterology and Hepatology (National) (06 Apr 2018 - 08 Apr 2018)
  6. A comparison of the HepaFat-Scan and FibroScan controlled attenuation parameter in the estimation of hepatic steatosis in patients with nonalcoholic fatty liver disease using histology as the reference standard, 13Th Asian - Australasian Federation of intervention and Therapeutic Neuroradiology (AAFITN 2018) , Asian-Australasian Federation of Interventional and Therapeutic Neuroradiology (AAFITN) (International) (07 Mar 2018 - 09 Mar 2018)
  7. Do the same-cut-off values for controlled attenuation parameter (CAP) apply for both M probe and XL probe of transient elastography [Fibroscan]?, Asia Pacific Digestive Week (APDW) 2017 Hong Kong, Asia Pacific Digestive Week (APDW) 2017 (International) (23 Sep 2017 - 26 Sep 2017)
  8. Comparing the BCLC and HKLC Staging System in the Management of Hepatocellular Carcinoma in a Tertiary Center in Malaysia, Annual Scientific Congress Malaysian Society of Gastroenterology and Hepatology, GUT 2017, Malaysian Society of Gastroenterology and Hepatology (National) (11 Aug 2017 - 13 Aug 2017)
  9. A randomized, double-blind, placebo-controlled study on silymarin for the treatment of non-alcoholic steatohepatits, The 25th Conference of the Asia Pacific Association for the Study of the Liver, The Asia Pacific Association for the Study of the Liver (International) (23 Feb 2016 - 23 Feb 2016)
  10. Silymarin for the treatment of Non-Alcoholic Steatohepatitis: Interim Analysis of a Randomized, Double-Blind,Placebo-Controlled Trial, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, Malaysian Society of Gastroenterology and Hepatology (National) (21 Aug 2015 - 23 Aug 2015)
  11. Progression of non-alcoholic fatty liver disease (NAFLD) a prospective clinicopathological follow-up study, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, Malaysian Society of Gastroenterology and Hepatology (National) (23 Aug 2013 - 23 Aug 2013)
  12. Prevalence of NAFLD among Patients in the Outpatient Diabetic Clinic of a Malaysian Tertiary Care Hospital , Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, Malaysian Society of Gastroenterology and Hepatology (National) (29 Jun 2012)
POSTER PRESENTER
  1. THE USE OF NON-INVASIVE TESTS COMPARED WITH HISTOLOGICAL FIBROSIS STAGE IN PREDICTING LIVER-RELATED EVENTS IN METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2022, The Malaysian Society of Gastroenterology and Hepatology  (National) (19 Aug 2022 - 21 Aug 2022)
  2. VALIDATION OF THE HEPAMET FIBROSIS SCORE IN A MULTI-ETHNIC ASIAN POPULATION, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2022, The Malaysian Society of Gastroenterology and Hepatology  (National) (19 Aug 2022 - 21 Aug 2022)
  3. FREQUENCY OF SIGNIFICANT FIBROSIS IN VARIOUS CHRONIC LIVER DISEASES: AN EVALUATION WITH TRANSIENT ELASTOGRAPHY (TE), Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2022, The Malaysian Society of Gastroenterology and Hepatology (National) (19 Aug 2022 - 21 Aug 2022)
  4. FREQUENCY OF SIGNIFICANT STEATOSIS IN VARIOUS CHRONIC LIVER DISEASES: AN EVALUATION WITH TRANSIENT ELASTOGRAPHY, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2022, The Malaysian Society of Gastroenterology and Hepatology (National) (19 Aug 2022 - 21 Aug 2022)
  5. Efficacy & safety of ravidasvir + sofosbuvir in hepatitis C: STORM-C-1 final results, Conference on Retroviruses and Opportunistic Infections, International Antiviral Society USA (IAS USA) (International) (12 Feb 2022 - 16 Feb 2022)
  6. Concordance between FibroScan and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia, International Viral Hepatitis Elimination Meeting (IVHEM) 2020, Drugs for Neglected Diseases initiative (DNDi) (International) (04 Dec 2020 - 05 Dec 2020)
  7. Comparison of attenuation parameter and liver stiffness measurement using fibrotouch vs fibroscan in patients with chronic liver disease , Annual Scientific of MSGH Virtual GUT 2020, Malaysian Society of Gastroenterology and Hepatology (International) (27 Nov 2020 - 29 Nov 2020)
  8. Patient-reported outcomes in patients with chronic Hepatitis C: data from The Global Liver Registry , The Liver Meeting Digital Experience, American Association for the Study of Liver Diseases (International) (13 Nov 2020 - 16 Nov 2020)
  9. The impact of chronic Hepatitis B on patient-reported outcomes from The Global Liver Registry , The Liver Meeting Digital Experience, American Association for the Study of Liver Diseases (International) (13 Nov 2020 - 16 Nov 2020)
  10. Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH registry , The Liver Meeting Digital Experience, Americal Association for the Study of Liver Diseases (International) (13 Nov 2020 - 16 Nov 2020)
  11. Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians, The Liver Meeting Digital Experience , American Association for the Study of Liver Diseases (AASLD) (International) (13 Nov 2020 - 16 Nov 2020)
  12. Comparison of attenuation parameter and liver stiffness measurement using fibrotouch vs fibroscan in patients with chronic liver disease, The Liver Meeting Digital Experience, American Association for the Study of Liver Diseases (International) (13 Nov 2020 - 16 Nov 2020)
  13. Impact of Hepatic Steatosis on Patients with Chronic Hepatitis B, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, Asia Pacific Association for the Study of Liver (International) (20 Feb 2019 - 24 Feb 2019)
  14. Prescription of statin and treatment targets in non-alcoholic fatty liver disease patients , 28th Annual Conference of the Asia Pacific Association for the Study of Liver, Asia Pacific Association for the Study of Liver (International) (20 Feb 2019 - 24 Feb 2019)
  15. Severity of NAFLD across Asian countries and predictors of severe disease, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, Asia Pacific Association for the Study of Liver (International) (20 Feb 2019 - 24 Feb 2019)
  16. Association between the components of metabolic syndrome and histological severities in patients with non-alcoholic fatty liver disease , 28th Annual Conference of the Asia Pacific Association for the Study of Liver, Asia Pacific Association for the Study of Liver (International) (20 Feb 2019 - 24 Feb 2019)
  17. MACK-3 (Combination of hoMa, Ast, CK18): a promising novel biomarker for fibrotic non-alcoholic steatohepatitis , 28th Annual Conference of the Asia Pacific Association for the Study of Liver, Asia Pacific Association for the Study of Liver (International) (20 Feb 2019 - 24 Feb 2019)
  18. Macroscopic On-site Quality Evaluation (MOSE) of Biopsy Specimens to Improve The Diagnostic Accuracy During EUS-Guided FNA Using a 19G Needle for Solid Lesions: A Prospective Randomized Controlled Study., Digestive Disease Week Scientific Sessions 2018 , Digestive Disease Week (International) (02 Jun 2018 - 05 Jun 2018)
  19. Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotype 1,2,3,and 6 The STORM-C-1 phase IIIII trial, The International Liver Congress 2018, EASL-The Home of Hepatology (International) (11 Apr 2018 - 15 Apr 2018)
  20. A non-invasive biomarker of hepatic inflammation based on magnetic resonance imaging. Journal of Hepatology, The International Liver Congress 2018, EASL-The Home of Hepatology (International) (11 Apr 2018 - 15 Apr 2018)
  21. Comparison of HepaFat-Scan and controlled attenuation parameter for the estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease using histology as the reference standard, The International Liver Congress 2018, EASL-The Home of Hepatology (International) (11 Apr 2018 - 15 Apr 2018)
  22. A pilot study of empagliflozin for the treatment of non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus, The International Liver Congress 2018, EASL-The Home of Hepatology (International) (11 Apr 2018 - 15 Apr 2018)
  23. Do the same-cut-off values for controlled attenuation parameter (CAP) apply for both M probe and XL probe of transient elastography [Fibroscan]?, Annual Scientific Congress Malaysian Society of Gastroenterology and Hepatology, GUT 2017, Malaysian Society of Gastroenterology and Hepatology (National) (11 Aug 2017 - 13 Aug 2017)
  24. A Substantial Proportion of Patients with Chronic Hepatitis B have a Significant Fibrosis and Concomitant Fatty Liver: Results from a Cross-Sectional Study using Fibroscan at a Major Tertiary Hospital in Malaysia, Annual Scientific Congress Malaysian Society of Gastroenterology and Hepatology, GUT 2017, Malaysian Society of Gastroenterology and Hepatology (National) (11 Aug 2017 - 13 Aug 2017)
  25. Comparing the BCLC and HKLC Staging System in the Management of Hepatocellular Carcinoma in a Tertiary Center in Malaysia, Annual Scientific Congress Malaysian Society of Gastroenterology and Hepatology, GUT 2017, Malaysian Society of Gastroenterology and Hepatology (National) (11 Aug 2017 - 13 Aug 2017)
  26. Non-alcoholic fatty liver disease - demographic features, risk factors and treatment practices across the Asia Pacific region -GO ASIA initiative, The International Liver Congress 2017, European Association for the Study of the Liver (EASL) (International) (19 Apr 2017 - 23 Apr 2017)
  27. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein as a serum biomarker for disease severity in non-alcoholic fatty liver disease, The International Liver Congress 2017, European Association for the Study of the Liver (EASL) (International) (19 Apr 2017 - 23 Apr 2017)
  28. Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, APDW 2016 Kobe (International) (02 Nov 2016 - 05 Nov 2016)
  29. Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, APDW 2016 Kobe (International) (02 Nov 2016 - 05 Nov 2016)
  30. A Study of Non-Alcoholic Fatty Liver Disease Using Trasient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-Aged Malaysian Cohort, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National) (22 Jul 2016 - 24 Jul 2016)
  31. A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National) (22 Jul 2016 - 24 Jul 2016)
  32. Is Silymarin Useful for the Treatment of Non- Alcoholic Fatty Liver Disease?: A Meta Analysis, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National) (22 Jul 2016 - 24 Jul 2016)
  33. Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Balloning in Adult NAFLD Patients: Non Invalsive Biomarkers in Diagnosis of Non Alcoholic Steatohapetitis (NASH) In Adult patients, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National) (22 Jul 2016 - 24 Jul 2016)
  34. Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study, Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National) (22 Jul 2016 - 24 Jul 2016)
  35. An Overview and Practical Management of Non-Alcoholic Fatty Liver Disease, 56TH ANNUAL GENERAL MEETING & ANNUAL SCIENTIFIC CONGRESS, PRIVATE MEDICAL PRACTITIONERS'S ASSOCIATION OF SELANGOR AND KUALA LUMPUR (PMPASKL) (National) (23 Apr 2016 - 24 Apr 2016)
  36. Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis, The International Liver Congress 2016, EASL (EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER) (International) (13 Apr 2016 - 17 Apr 2016)
  37. Increasing Obesity and GI diseases in ASIA Gut and Obesity in Asia (GOASIA) consensus statements on obesity and gastrointestinal diseases, Asian Pacific Digestive Week 2015, Asian Pacific Digestive Week Federation  (International) (03 Dec 2015 - 06 Dec 2015)
  38. Silymarin for the treatment of non-alcoholic steatohepatitis: Interim analysis of a randomized, double-blind, placebo-controlled trial, Asian Pacific Digestive Week 2015, Asian Pacific Digestive Week Federation  (International) (03 Dec 2015 - 06 Dec 2015)
  39. Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease?, Asian Pacific Digestive Week 2015, Asian Pacific Digestive Week Federation (International) (03 Dec 2015 - 06 Dec 2015)
  40. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial., International Liver Conference 2015 (International) (01 Jun 2015)
  41. A novel 2 step approach combining the nafld fibrosis score and liver stiffness measurement for predicting advanced fibrosis, Asia Pacific Association for the Study of Liver 2015 Meeting (International) (01 Jun 2015)
  42. Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers., Asia Pacific Association for the Study of Liver 2015 Meeting (International) (01 Jun 2015)
  43. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. , Asia Pacific Digestive Week 2014 (24 Nov 2014 - 24 Nov 2014)
  44. Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease., Asia Pacific Digestive Week 2014 (24 Nov 2014 - 24 Nov 2014)
  45. Controlled Attenuation Parameter for The Detection and Quantification of Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease, GUT 2014 and ECCO Educational Workshop , Malaysian Society of Gastroenterology and Hepatology (National) (22 Aug 2014 - 24 Aug 2014)
  46. Combination of NAFLD Fibrosis Score and Liver Stiffness Measurement for Predicting Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease, GUT 2014 and ECCO Educational Workshop , Malaysian Society of Gastroenterology and Hepatology  (National) (22 Aug 2014 - 24 Aug 2014)
  47. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers, GUT 2014 and ECCO Educational Workshop, Malaysian Society of Gastroenterology and Hepatology (National) (22 Aug 2014 - 24 Aug 2014)
  48. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease, 23rd Conference of the Asian Pacific Association in the Study of the Liver 2014, Asian Pacific Association in the Study of the Liver  (International) (12 Mar 2014 - 15 Mar 2014)
  49. US-Diagnosed NAFLD Is Not Associated with IHD among Long-Standing Poorly-Controlled Diabetics, Gastro 2013 Asia Pacific Digestive Week / World Congress of Gastroenterology Shanghai, Asia Pacific Digestive Week Federation, Chinese Societies of Digestive Diseases, World Endoscopy Organization, and World Gastroenterology Organization  (International) (23 Sep 2013)
  50. Prevalence of NAFLD and Associated Factors in a Young Multi-Racial Malaysian Population, Gastro 2013 Asia Pacific Digestive Week / World Congress of Gastroenterology Shanghai, Asia Pacific Digestive Week Federation, Chinese Societies of Digestive Diseases, World Endoscopy Organization, and World Gastroenterology Organization  (International) (23 Sep 2013)
  51. Split Versus Whole-Dose PEG-ELS For Bowel Preparation In Outpatient Colonoscopy, Gastro 2013 Asia Pacific Digestive Week / World Congress of Gastroenterology Shanghai, Asia Pacific Digestive Week Federation, Chinese Societies of Digestive Diseases, World Endoscopy Organization, and World Gastroenterology Organization (International) (22 Sep 2013)
  52. Non-alcoholic fatty liver disease in young adults worrying ethnic differences in a multi-racial Asian population in Malaysia, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, Malaysian Society of Gastroenterology and Hepatology (National) (23 Aug 2013 - 25 Aug 2013)
  53. Low physical activity and high percentage calorie intake from fat, high cholesterol food and high saturated fatty acid food is associated with NAFLD in centrally obese diabetics, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, Malaysian Society of Gastroenterology and Hepatology (National) (23 Aug 2013 - 25 Aug 2013)
  54. Ultrasonography-diagnosed non-alcoholic fatty liver disease (NAFLD) is not associated with prevalent ischemic heart disease (IHD) among long-standing poorly controlled diabetics., Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, Malaysian Society of Gastroenterology and Hepatology (National) (23 Aug 2013 - 25 Aug 2013)
  55. Reduced-volume PEG-ELS plus bisacodyl split-dose is better than same morning whole-dose for morning outpatient colonoscopy: result of an investigator- and endoscopist-blinded, randomized study, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, Malaysian Society of Gastroenterology and Hepatology (National) (23 Aug 2013 - 25 Aug 2013)
  56. Clinical and Histological Follow-Up of a Cohort of Patients with NAFLD, Asian Pacific Digestive Week: Achieving Excellence in Gastroenterology & Hepatology, Asian Pacific Digestive Week Federation, Asian Pacific Association of Gastroenterology, Asian Pacific Association for the Study of Liver, Asian Pacific Society for Digestive Endoscopy and International Society for Digestive Surgery (05 Dec 2012 - 08 Dec 2012)
  57. Prevalence of NAFLD among Diabetic Patients in the Outpatient Clinic of a Malaysian Hospital and Associated Factors, Asian Pacific Digestive Week 2012: Achieving Excellence in Gastroenterology & Hepatology, Asian Pacific Digestive Week Federation, Asian Pacific Association of Gastroenterology, Asian Pacific Association for the Study of Liver, Asian Pacific Society for Digestive Endoscopy and International Society for Digestive Surgery (International) (05 Dec 2012 - 08 Dec 2012)
  58. The Role of Diet and Physical Activity in Non-Alcoholic Fatty Liver Disease (NAFLD) in Diabetic Patients, The 3rd Asian-Pacific Topic Conference: Nutritional Related Disorders and Digestive System, Japanese Society of Gastroenterology (JSGE) and Asian Pacific Association of Gastroenterology (APAGE) (International) (02 Nov 2012 - 03 Nov 2012)
  59. Endoluminal Clipping Versus Surgery In The Management Of Iatrogenic Colonic Perforation: A Direct Cost Analysis , Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, Malaysian Society of Gastroenterology and Hepatology (National) (29 Jun 2012 - 01 Jul 2012)
  60. Clinical and Histological Follow-Up of a Cohort of Patient with Non-Alcoholic Fatty Liver Disease (NAFLD), Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, Malaysian Society of Gastroenterology and Hepatology (National) (29 Jun 2012 - 01 Jul 2012)
  61. Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital, Asia Pacific Digestive Week 2011: Integrating Science and Technology in Clinical Gastroenterology, Asia Pacific Digestive Week Federation (International) (01 Oct 2011 - 04 Oct 2011)
  62. Patient satisfaction of outpatient gastroscopy in University of Malaya Medical Centre Endoscopy Unit , Asia Pacific Digestive Week 2011: Integrating Science and Technology in Clinical Gastroenterology, Asia Pacific Digestive Week Federation (International) (01 Oct 2011 - 04 Oct 2011)
  63. Patient satisfaction of outpatient gastroscopy in University Malaya Medical Centre endoscopy unit., Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011 (National) (01 Mar 2011)
  64. Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital., Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011 (National) (01 Mar 2011)
  65. Patient satisfaction with various aspects of an outpatient colonoscopy service, Asia Pacific Digestive Week 2010: Gastroenterology in Asia Pacific - Excellence in the New Decade, Malaysian Society of Gastroenterology and Hepatology (International) (19 Sep 2010 - 22 Sep 2010)
  66. Risk factors for poor bowel preparation and its impact on technical performance and patient comfort in an Asian population, Asia Pacific Digestive Week 2010: Gastroenterology in Asia Pacific - Excellence in the New Decade, Malaysian Society of Gastroenterology and Hepatology (International) (19 Sep 2010 - 22 Sep 2010)
PRESENTER
  1. Current Therapies - What Has Promise? What Does Not?, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology (GUT2018), Malaysian Society of Gastroenterology and Hepatology  (International) (13 Jul 2018 - 15 Jul 2018)
  2. Outcomes of Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD) in South East Asian Patients: A Single Tertiary Center Experience, Annual Scientific Congress of the Malaysian Society of Gastroenterology and Hepatology GUT 2017, Malaysian Society of Gastroenterology and Hepatology (International) (11 Aug 2017 - 13 Aug 2017)
  3. An Asian Multicentre Study On Biopsy-Proven NAFLD Patients-Part of The GO ASIA Initiative, Asian Pacific Digestive Week APDW 2016, Asian Pacific Digestive Week APDW 2016 Kobe (International) (02 Nov 2016 - 05 Nov 2016)
  4. Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, APDW 2016 Kobe (International) (02 Nov 2016 - 05 Nov 2016)
  5. Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, APDW 2016 Kobe (International) (02 Nov 2016 - 05 Nov 2016)
  6. New Therapeutic Options for NAFLD, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, APDW 2016 Kobe (International) (02 Nov 2016 - 05 Nov 2016)
  7. A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National) (22 Jul 2016 - 24 Jul 2016)
  8. Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National) (22 Jul 2016 - 24 Jul 2016)
  9. Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis, The International Liver Congress 2016, EASL (EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER) (International) (13 Apr 2016 - 17 Apr 2016)
  10. Infected Walled-Off Necrosis with Disrupted Main Pancreatic Duct Following Acute Gallstone Pancreatitis, Asian Young Endoscopists Award (AYEA) 2015, Korean Society of Gastrointestinal Endoscopy (International) (07 Sep 2015 - 18 Sep 2015)
  11. Fat in the liver - get it checked before it's too late!, Wednesday Morning Symposium (Others) (14 Aug 2013 - 14 Aug 2013)
  12. A case of autoimmune liver cirrhosis, First Klang Valley GI Updates 2010/2011, Malaysian Society of Gastroenterology and Hepatology (National) (09 Jan 2011 - 09 Jan 2011)
KEYNOTE SPEAKER
  1. Interventional Studies, including Randomized Controlled Trials, Asian Pacific Digestive Week 2023, Asian Pacific Digestive Week Federation (International) (05 Dec 2023 - 05 Dec 2023)
  2. Asia Pacific guidelines on Metabolic-Associated Fatty Liver Disease (MAFLD), 33rd Malaysian Association of Clinical Biochemists (MACB), Malaysian Association of Clinical Biochemists (International) (04 Sep 2023 - 06 Sep 2023)
OTHERS
  1. Participant, 20th PGI-AIIMS Current Perspectives in Liver Disease-CPLD 2020 Virtual Conference, Department of Hepatology, PGIMER, Chandigarh and Department of Gastroenterology AIIMS, New Delhi (International) (10 Oct 2020 - 11 Oct 2020)
  2. Participant, 2nd BEL-G - Bariatric Endoscopy Live Global, Gastroentestinal Endoscopy Unit, University of Sao Paulo and Division of gastroenterology, Hepatology and Endoscopy, Harvard Medical School (International) (02 Oct 2020 - 02 Oct 2020)
  3. 18th MSGH Oration: Hepatitis E in Asia, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology (GUT 2018), Malaysian Society of Gastroenterology and Hepatology (International) (13 Jul 2018 - 15 Jul 2018)
  4. NASH and HCV, Singapore Hepatology Conference 2018, Singapore Hepatitis Conference Pte Ltd (International) (08 Jun 2018 - 09 Jun 2018)
  5. Participant, Asia-Pacific Digestive Week (APDW) 2017, Asia-Pacific Digestive Week (APDW) Federation (International) (24 Sep 2017 - 26 Sep 2017)
  6. Participant, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology, GUT 2017, Malaysian Society of Gastroenterology and Hepatology (National) (11 Aug 2017 - 13 Aug 2017)
  7. Early Morning HBV Workshop 3 (half the participants): Case discussion- management of difficult to treat cases NASH & HCV., Singapore Hepatology Conference 2017, Singapore Hepatitis Conference Pte Ltd (International) (02 Jun 2017 - 03 Jun 2017)
  8. Participant, Calibration Workshop: Masters of Medicine (Internal Medicine), Faculty of Medicine and Health Sciences, University Putra Malaysia (UPM) (National) (07 May 2017 - 07 May 2017)
  9. Participant, The International Liver Congress 2017, EASL, European Association for the Study of the Liver (International) (19 Apr 2017 - 23 Apr 2017)
  10. Participant, Flexible Endoscopic Surgery course, Flexible Endoscopic Surgery & Bariatric Endoscopy  (International) (17 Mar 2017 - 18 Mar 2017)
  11. Participant, 2017 OverStitch Advanced Suturing Course , Flexible Endoscopic Surgery & Bariatric Endoscopy (International) (16 Mar 2017 - 16 Mar 2017)
  12. Participant, The 2nd Asan Medical Center EUS-guided Radiofrequency Ablation Training Program, ASAN Medical Center and TaeWoong Medical (International) (06 Jan 2017 - 07 Jan 2017)
  13. Participant, The 25th Conference of the Asia Pacific Association for the Study of the Liver, The Asia Pacific Association for the Study of the Liver (International) (20 Feb 2016 - 24 Feb 2016)
  14. Participant, Postgraduate Course, American Association for The Study Of Liver Diseases (AASLD) (International) (14 Nov 2015)
  15. Participant, The Liver Meeting, American Association for The Study Of Liver Diseases (AASLD) (International) (13 Nov 2015 - 17 Nov 2015)
  16. Participant, Stanford Preceptorship , School of Medicine, Stanford University (International) (10 Nov 2015 - 11 Nov 2015)
  17. Participant, Asian EUS Congress 2015, Asian EUS Group (International) (11 Sep 2015 - 12 Sep 2015)
  18. Participant, Asian Young Endoscopists Award (AYEA) 2015, Korean Society of Gastrointestinal Endoscopy (International) (07 Sep 2015 - 18 Sep 2015)
  19. Participant, Hepato Metabolic GP Workshop, MEDA Rottapharm Madaus (National) (05 Sep 2015 - 06 Sep 2015)
  20. Participant, Workshop on Developing A Protocol For Cochrane Systematic Review , Julius Centre University of Malaya (University) (24 Aug 2015 - 27 Aug 2015)
  21. Moderator, GUT 2015 Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology, Malaysian Society of Gastroenterology and Hepatology (National) (21 Aug 2015 - 23 Aug 2015)
  22. Participant, GUT 2015 Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology, Malaysian Society of Gastroenterology and Hepatology  (National) (21 Aug 2015 - 23 Aug 2015)
  23. Participant, Train the Trainer, Asian EUS Group (International) (20 Aug 2015 - 21 Aug 2015)
  24. Visiting Fellow, Endoscopic Ultrasonography, Asian Institute of Gastroenterology, Hyderabad (04 May 2015 - 08 May 2015)
  25. Participant, Endoscopy 2015 , University of Malaya & Malaysian Society of Gastroenterology and Hepatology  (International) (17 Apr 2015 - 19 Apr 2015)
  26. Moderator , Endoscopy 2015, University of Malaya & Malaysian Society of Gastroenterology and Hepatology (International) (17 Apr 2015 - 19 Apr 2015)
  27. Participant, Asian Pacific Digestive Week 2014, Asian Pacific Digestive Week Federation (International) (22 Nov 2014 - 25 Nov 2014)
  28. Participant, Postgraduate Course, Asian Pacific Digestive Week Federation  (International) (22 Nov 2014)
  29. Assistant Course Director, 2014 Advanced EUS Workshop, University of Malaya Medical Centre (National) (13 Oct 2014)
  30. Participant, SGI 2014 the Society of Gastrointestinal Intervention , SGI 2014 the Society of Gastrointestinal Intervention (International) (03 Oct 2014 - 04 Oct 2014)
  31. Participant, EUS2014 19th International Symposium On Endoscopic Ultrasonography, EUS2014 19th International Symposium On Endoscopic Ultrasonography (International) (18 Sep 2014 - 20 Sep 2014)
  32. Participant, GUT 2014 and ECCO Educational Workshop , Malaysian Society of Gastroenterology and Hepatology (National) (22 Aug 2014 - 24 Aug 2014)
  33. Participant, The 5th Asia-Pacific Primary Liver Cancer Expert Meeting, APPLE 2014 (International) (11 Jul 2014 - 13 Jul 2014)
  34. Asian EUS Group Annual Trainers Retreat 2014, Asian EUS Group Annual Trainers Retreat 2014, GIHEP Singapore 2014 (International) (21 Jun 2014 - 22 Jun 2014)
  35. The New Era in Clinical Management of Liver Fibrosis, 2nd Asia Liver Fibrosis Forum, CFHPC (International) (24 May 2014)
  36. Faculty, Asian EUS Group Workshop, University of Malaya (National) (30 Mar 2014)
  37. Participant, Endoscopy 2014: The Best Tips in Therapeutic Endoscopy, University of Malaya (28 Mar 2014 - 30 Apr 2014)
  38. Participant, MSGH Update in Gastroenterology and Hepatology, Malaysian Society of Gastroenterology and Hepatology (National) (15 Feb 2014)
  39. Participant, Gastroenterology Workshop 2013 (24 Oct 2013 - 25 Oct 2013)
  40. Techniques of Addressing Nonconformance Reports & Root Cause Analysis, Techniques of Addressing Nonconformance Reports & Root Cause Analysis Training (11 Sep 2013 - 12 Sep 2013)
  41. Delegate, APASL Liver Week , The Gastroenterological Society of Singapore and The Asian Pacific Association for the Study of the Liver  (International) (06 Jun 2013 - 10 Jun 2013)
  42. Delegate, The International Liver Congress 2013, The European Association for the Study of the Liver (International) (24 Apr 2013 - 28 Apr 2013)
  43. Participant, Asian EUS Group Workshop 2013, University of Malaya and Malaysian Society of Gastroenterology and Hepatology (National) (14 Apr 2013)
  44. Participant, The 2nd Mumbai Interventional EUS Course, The Association of Interventional GI Endoscopy of India, The Baldota Institute of Digestive Sciences and The Asian EUS Group (International) (30 Mar 2013 - 31 Mar 2013)

ACADEMIC/PROF. SERVICES


Evaluation
  1. (2024) Appointment as External Examiner for a Phd Candidate, National, (External Examiner)
  2. (2024) Evaluation Panel for Frgs Grants, National, (Reviewer)
  3. (2023) Referee for Promotion Application - Dr. Farhi Ain Binti Jamaluddin, University, (Internal Evaluator)
  4. (2022) Panel Reviewer for Department of Medicine-Research Support Fund (Dom-Rsf) Cycle 3, 2022, University, (Reviewer)
  5. (2022) Reviewer for a Manuscript Entitled "M-Past Score is Better Than Mast and Fast for The Diagnosis of Active Fibrotic Nash", International, (Reviewer)
  6. (2022) Reviewer for a Manuscript Entitled 'Mafld:What 2 Years of The Redefinition of Fatty Liver Disease Has Taught Us', International, (Reviewer)
  7. (2022) Reviewer for a Manuscript, International, (Reviewer)
  8. (2022) Reviewer for Article in Journal, International, (Reviewer)
  9. (2022) Reviewer for Two Manuscripts, International, (Reviewer)
  10. (2021) Reviewer for a Manuscript, International, (Reviewer)
  11. (2021) Examiner for Master's in Internal Medicine Examination, University, (Internal Examiner)
Contribution to external organisation
  1. (2024) Expert Panel Global Nash Council Meeting, International, (Technical Advisor)
  2. (2024) Expert Panel Abbott Liver Expert Meeting, International, (Technical Advisor)
  3. (2024) Expert Advisor for Boehringer Ingelheim Survodutide Mash Advisory Board, International, (Technical Advisor)
  4. (2024) Appointment as Supervisor, National, (Academic Appointment )
  5. (2024) Member of International Research Collaborative Group, International, (Expert Advisor)
  6. (2024) Member of International Research Collaborative Group, International, (Expert Advisor)
  7. (2024) Member of International Collaborative Research Group, International, (Expert Advisor)
  8. (2024) Member of International Collaborative Research Group, International, (Expert Advisor)
  9. (2024) Member of International Collaborative Research Group, International, (Expert Advisor)
  10. (2023) Member of International Collaborative Research Group, International, (Expert Advisor)
  11. (2022) Developing An International Delphi Consensus On Metabolic Dysfunction-Associated Fatty Liver Disease (Mafld) and The Risk of Cardiovascular Disease (Cvd), International, (Expert Advisor)
  12. (2022) Member of International Collaborative Group, International, (Expert Advisor)
Contribution to event
  1. (2024) Participant (Endoscopy Workshop 2024), International, (Participant)
  2. (2024) Participant of The 33rd Annual Meeting of The Asian Pacific Association for The Study of The Liver (Apasl 2024), International, (Participant)
  3. (2024) Participation in Essence Expert Advisor Meeting, International, (Participant)
  4. (2023) Moderator for The Interactive Session 1, International, (Panelist/Moderator)
  5. (2023) Course Director for Young Clinician Investigator Program, International, (Course Facilitator)
  6. (2023) Moderator for Live Demo 1, International, (Panelist/Moderator)
  7. (2023) Moderator for State-of-The-Art-Lecture 4, International, (Panelist/Moderator)
  8. (2023) Participant of Endoscopy Workshop 2023, International, (Participant)
  9. (2022) Nafld: The Big Picture, National, (Panelist/Moderator)
  10. (2022) Participant of The Annual Scientific Congress, National, (Participant)
  11. (2022) Postgraduate Course 4 Hepatology, International, (Panelist/Moderator)
  12. (2022) Attending a Meeting, National, (Participant)
  13. (2022) Tea Satellite Symposium 2, National, (Panelist/Moderator)
  14. (2022) Symposium 1 The Msgh Consensus Statements On Mafld, National, (Panelist/Moderator)
  15. (2022) Participant of a Meeting, National, (Participant)
  16. (2022) Course Coordinator for Young Gi Consultant Forum, International, (Event Coordinator)
  17. (2022) Participant of Endoscopy Workshop 2022, International, (Participant)
  18. (2022) Chairperson for Advanced Liver Disease Symposium, International, (Panelist/Moderator)
  19. (2022) Chairperson for Non-Alcoholic Fatty Liver Disease Symposium, International, (Panelist/Moderator)
  20. (2022) Participant for Novo Nordisk Local Investigator Meeting, International, (Participant)
  21. (2021) Speaker (Nafld: Placing The Liver On Diabetes Maps) At The Diabetes Malaysia Webinar Series, National, (Panelist/Moderator)
  22. (2021) Speaker ( An Update On The Management of Chronic Hepatitis B) At The World Pharmacist Day, University, (Panelist/Moderator)
  23. (2021) Speaker (Obesity and Fatty Liver) At The Nursing Webinar Session 23/2021, University, (Panelist/Moderator)
  24. (2021) Program Director for Nafld Mafld Sig Program, International, (Event Coordinator)
  25. (2021) Chairperson for Nafld Mafld Sig Program 3, International, (Panelist/Moderator)
  26. (2021) Speaker (Interventional Studies, Including Randomized Controlled Trial) During Apdwf-Jghf Young Clinician Investigator Program, International, (Panelist/Moderator)
  27. (2021) Chairperson for Ravidasvir: Newer and Better Daa?, International, (Panelist/Moderator)
  28. (2021) Speaker (Analysis of Continuous Data) During Apdwf-Jghf Young Clinician Investigator Program, International, (Panelist/Moderator)
  29. (2021) Speaker (Case Discussion) for Nafld Mafld Sig Program 1 During Virtual Apdw 2021, International, (Panelist/Moderator)
  30. (2021) Chairperson for Nafld Mafld Sig Program 2, International, (Panelist/Moderator)
  31. (2021) Organizing Committee for Virtual Apdw 2021, International, (Event Organiser)
  32. (2021) Facilitator for Practical Session During Apdwf-Jghf Young Clinician Investigator Program, International, (Course Facilitator)
  33. (2021) Chairperson for Nafld Mafld Sig Program 1, International, (Panelist/Moderator)
  34. (2021) Speaker (My Patient Has Nafld - So What??) At Mems Annual Congress 2021, National, (Panelist/Moderator)
  35. (2021) Participant of Mems Annual Congress 2021, National, (Participant)
  36. (2021) Speaker (Diet and Exercise: Which One Plays a More Important Role?) At Apasl 2021, International, (Panelist/Moderator)
  37. (2021) Speaker (Nafld-Mafld: New Definition and Cardiovascular Risk) At Apasl 2021, International, (Panelist/Moderator)
  38. (2021) Speaker (Nafld and T2dm: Two Sides of The Same Coin) At Virtual Cgp Management of T2dm, National, (Panelist/Moderator)
  39. (2021) Moderator for Session Entitled "The Landscape for Upcoming Nash Therapy", International, (Panelist/Moderator)
Media appearance
  1. (2023) Speaker for a Radio Podcast (Doctor in The House: Fatty Liver On The Rise), National, (Panelist/Moderator)

SUPERVISION


Postgraduate Student
PhD/ Doctoral
  1. (2024) THE TRENDS AND FACTORS ASSOCIATED WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG ADOLESCENTS, VISHNU RAJ A/L SAVUMTHARARAJ
  2. (2020) FILLING THE GAPS IN NON-ALCOHOLIC FATTY LIVER DISEASE - FROM SCREENING TO ASSESSMENT AND TREATMENT, LAI LEE LEE
  3. (2015) Prevalence of advanced fibrosis due to non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus, Lai Lee Lee
Master
  1. (2022) Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Liver Fibrosis Among Hemodialysis Patients in a Multiracial Urban Population in Malaysia, WONG WEI KEI
  2. (2020) IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHRONIC HEPATITIS B, WONG SUI WENG
  3. (2018) Sarjana Perubatan Dalaman, Ang Chui Mun
  4. (2016) SARJANA PERUBATAN DALAMAN, Leong Lai Kuan
  5. (2015) Shear wave elastography imaging for assessment of liver fibrosis in non-alcoholic fattyliver disease: correlation with transient elatography and histopathologic evaluation, Leong Wai Ling
  6. (2015) MRI-based classification of liver fibrosis, Syaman a/l Harry
  7. (2015) Fibroscan as a non-invasive approach to predict the presence and size of varices in the Malaysian cirrhotic population, Lee Chong Chearn
  8. (2015) Fibroscan as a non-invasive approach to predict the presence and size of varices in the Malaysian cirrhotic population, Kavitha A/P Sahadivanaidu
  9. (2015) A study of non-alcoholic fatty liver disease using transient elastography and carotid intima media thickness using ultrasonography, Eugene Tan Choon Li
  10. (2013) Clinical Fellows in Gastroenterology, Dr. Suresh Sithambaram
  11. (2010) Patient Satisfaction of Outpatient Gastroscopy in University Malaya Medical Centre Endoscopy Unit, Ahmad Najib bin Azmi
  12. (2010) Masters Degree in Internal Medicine, Nor Suraya Samsudin
Under Graduate Students
  1. (2024) Practices, ENG WENDY
  2. (2017) Mentor for MBBS Programme Kee Yan Shen
  3. (2015) MBBS, Sumitra Ropini, A review of hepatocellular carcinoma from 2011 to 2014 in University Malaya Medical Centre
  4. (2014) MBBS, Stacey Lim, A study on the vertical transmission of hepatitis B virus infection in Malaysia
  5. (2014) MBBS, Lai Su Meng, A study on the vertical transmission of hepatitis B virus infection in Malaysia
  6. (2014) MBBS, Jaclyn Lee, A study on the vertical transmission of hepatitis B virus infection in Malaysia
  7. (2014) MBBS, Andrew Yeoh, A study on the vertical transmission of hepatitis B virus infection in Malaysia
  8. (2013) MBBS, Tan Zhun Foo
  9. (2013) MBBS, Ong Jes Mon
  10. (2013) MBBS, Moh Jun Yuan
  11. (2012) MBBS, Tan Wen Nian, Randomized controlled trial: effect of split-dose versus whole-dose 2-liter polyethylene glycol electrolyte lavage solution (PEG-ELS) on quality of bowel preparation for colonoscopy
  12. (2012) MBBS, Choo Pee Terh, Randomized controlled trial: effect of split-dose versus whole-dose 2-liter polyethylene glycol electrolyte lavage solution (PEG-ELS) on patient tolerability of bowel preparation for colonoscopy
  13. (2011) MBBS, Yeoh Whei Chuern, Prevalence of fatty liver among outpatient diabetic patients in an Asian tertiary care hospital
  14. (2011) MBBS, Ooi Chung Ping, Risk factors for fatty liver among outpatient diabetic patients in an Asian tertiary care hospital

SOCIAL RESPONSIBILITY ACTIVITIES


  • Chairperson to Virtual Gut 2020-Annual Scientific Meeting of Msgh, (27 Nov 2020 - 29 Nov 2020)
  • Moderator for Bariatric Endoscopy Live Global, (02 Oct 2020 - 02 Oct 2020)
  • Organizing Committee for Asia Pacific Digestive Week 2020, (17 Sep 2020 - 20 Sep 2020)
  • Organising Committee of Asian Pacific Digestive Week 2020 as The Scientific Co-Chair-Hepatology, (17 Sep 2020 - 20 Sep 2020)
  • Bid Committee for Asia Pacific Digestive Week 2020, (17 Sep 2020 - 20 Sep 2020)
  • Moderator for Web Symposium Sea Nafld Summit 2020, (28 Jul 2020 - 28 Jul 2020)
  • Chairperson for Live Webinar: "Find The Missing Millions" (Advanced Treatments for Hepatitis), (26 Jul 2020 - 26 Jul 2020)
  • Chairperson for Annual Scientific Meeting of The Malaysian Society of Gastroenterology & Hepatology Gut2019, (16 Aug 2019 - 18 Aug 2019)
  • Chairperson for Annual Scientific Meeting of The Malaysian Society of Gastroenterology & Hepatology Gut2019, (16 Aug 2019 - 18 Aug 2019)
  • Organizing Committe for Annual Scientific Meeting of The Malaysian Society of Gastroenterology & Hepatology Gut2019, (16 Aug 2019 - 18 Aug 2019)
  • Organizing Committee for Annual Scientific Meeting of The Malaysian Society of Gastroenterology and Hepatology (Gut 2018), (13 Jul 2018 - 15 Jul 2018)
  • Organizing Committee for Annual Scientific Meeting Msgh (Gut 2018), (13 Jul 2018 - 15 Jul 2018)
  • Chairperson for Hepatitis B Symposium (Gut 2018), (13 Jul 2018 - 15 Jul 2018)
  • Chairperson for Hepatitis B Tea Satellite Symposium (Gut 2018), (13 Jul 2018 - 15 Jul 2018)
  • Co-Course Director for Basic Eus Course 2018, (06 Apr 2018 - 06 Apr 2018)
  • Co-Course Director for Endoscopy 2018, (06 Apr 2018 - 08 Apr 2018)
  • Organizing Committee for Msgh Update in Gastroenterology and Hepatology 2018, (03 Mar 2018 - 03 Mar 2018)
  • Organizing Committee for Gut 2017, (11 Aug 2017 - 13 Aug 2017)
  • Chairperson for Gut 2017, (11 Aug 2017 - 13 Aug 2017)
  • Chairperson of Annual Scientific Meeting of The Indian National Association for Study of The Liver (25th Silver Jubilee) 2017, (05 Aug 2017 - 05 Aug 2017)
  • Chairperson for Hot Topics in Hepatology Symposium, (02 Jun 2017 - 03 Jun 2017)
  • Coordinator for Endoscopy 2017, (07 Apr 2017 - 09 Apr 2017)
  • Course Co-Directors for Endoscopy 2017, (07 Apr 2017 - 09 Apr 2017)
  • Organizing Committee for Endoscopy 2017, (07 Apr 2017 - 09 Apr 2017)
  • Organizing Committee for Msgh Update in Gastroenterology and Hepatology, (04 Mar 2017 - 04 Mar 2017)
  • Chairperson in Asian Pacific Digestive Week Apdw 2016, (02 Nov 2016 - 05 Nov 2016)
  • Organizing Committee Gut 2016, (22 Jul 2016 - 24 Jul 2016)
  • Chairperson for Gut 2016, (22 Jul 2016 - 24 Jul 2016)
  • Organizing Committee for Endoscopy 2016, (08 Apr 2016 - 10 Apr 2016)
  • Co-Course Director for Eus-Cytopathology Hands-On Workshop 2015, (21 Dec 2015 - 21 Dec 2015)
  • Organizing Committee for 2015 Advanced Eus Workshop, (21 Dec 2015 - 21 Dec 2015)
  • Organizing Committee for Endoscopy 2015: Maintaining Quality in Endoscopy, (17 Apr 2015 - 19 Apr 2015)
  • Assistant Course Director for The 2nd Advanced Eus Workshop 2014, (13 Oct 2014 - 13 Oct 2014)
  • Organizing Committee for Endoscopy 2014: The Best Tips in Therapeutic Endoscopy, (28 Mar 2014 - 30 Mar 2014)
  • Course Coordinator for Basic Endoscopy Course 2013, (21 Jun 2013)
  • Course Coordinator for Gastrointestinal Motility Workshop 2013, (11 Jun 2013)
  • Assistant Course Coordinator for Asian Eus Group Workshop 2013, (14 Apr 2013)
  • Course Coordinator for Gia Course 2013, (12 Apr 2013)
  • Organizing Committee for Endoscopy 2013: Advancing The Practice of Endoscopy, (12 Apr 2013 - 14 Apr 2013)
  • Organizing Committee for Endoscopy 2012: Therapeutic Endoscopy in The Global World, (30 Mar 2012 - 01 Apr 2012)
  • Organizing Committee for 1st Erbe-Ummc Training Workshop in Therapeutic Endoscopy, (01 Jul 2011 - 01 Jul 2011)
  • Organizing Committee for Endoscopy 2011: What's New and What's Good for Our Patients, (14 Apr 2011 - 17 Apr 2011)